[S02DA03, antipyrine, The metabolism of Antipyrine can be decreased when combined with Chloroquine.]
[J01GA01, streptomycin, Chloroquine may decrease the excretion rate of Streptomycin which could result in a higher serum level.]
[M03AB01, succinylcholine, The therapeutic efficacy of Succinylcholine can be increased when used in combination with Chloroquine.]
[A02BX02, sucralfate, Sucralfate may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01CG01, sulbactam, Chloroquine may decrease the excretion rate of Sulbactam which could result in a higher serum level.]
[J01EC02, sulfadiazine, The risk or severity of methemoglobinemia can be increased when Sulfadiazine is combined with Chloroquine.]
[J01EC01, sulfamethoxazole, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Sulfamethoxazole.]
[J01EB04, sulfapyridine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Sulfapyridine.]
[S01AB02, sulfisoxazole, The risk or severity of QTc prolongation can be increased when Sulfisoxazole is combined with Chloroquine.]
[M01AB02, sulindac, Sulindac may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N05AL01, sulpiride, The risk or severity of QTc prolongation can be increased when Sulpiride is combined with Chloroquine.]
[N03AX03, sulthiame, The therapeutic efficacy of Sulthiame can be decreased when used in combination with Chloroquine.]
[M01AX04, apazone, Azapropazone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N06DA01, tacrine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Tacrine is combined with Chloroquine.]
[L02BA01, tamoxifen, The metabolism of Tamoxifen can be decreased when combined with Chloroquine.]
[N05CD07, temazepam, Temazepam may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01CB02, teniposide, The metabolism of Teniposide can be decreased when combined with Chloroquine.]
[R03CC03, terbutaline, The risk or severity of QTc prolongation can be increased when Terbutaline is combined with Chloroquine.]
[B01AE07, dabigatran etexilate, Chloroquine may decrease the excretion rate of Dabigatran etexilate which could result in a higher serum level.]
[G03BA03, testosterone, Chloroquine may decrease the excretion rate of Testosterone which could result in a higher serum level.]
[N07XX06, tetrabenazine, The metabolism of Tetrabenazine can be decreased when combined with Chloroquine.]
[S01HA03, tetracaine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Tetracaine.]
[S03AA02, tetracycline, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Tetracycline.]
[J01DI02, ceftaroline fosamil, Ceftaroline fosamil may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N05AE05, lurasidone, The risk or severity of QTc prolongation can be increased when Lurasidone is combined with Chloroquine.]
[A04AD10, dronabinol, The metabolism of Chloroquine can be decreased when combined with Dronabinol.]
[N04BC07, apomorphine, The metabolism of Apomorphine can be decreased when combined with Chloroquine.]
[L04AX02, thalidomide, The metabolism of Chloroquine can be increased when combined with Thalidomide.]
[R03DA07, theobromine, Theobromine may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03DA04, theophylline, The metabolism of Theophylline can be decreased when combined with Chloroquine.]
[P02CA02, thiabendazole, Chloroquine may decrease the excretion rate of Thiabendazole which could result in a higher serum level.]
[L01XX41, eribulin, The risk or severity of QTc prolongation can be increased when Eribulin is combined with Chloroquine.]
[R06AD03, thiethylperazine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Thiethylperazine.]
[N05CA19, thiopental, The therapeutic efficacy of Thiopental can be decreased when used in combination with Chloroquine.]
[N05AB08, thioproperazine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Thioproperazine.]
[N05AC02, thioridazine, The metabolism of Thioridazine can be decreased when combined with Chloroquine.]
[N05AF04, thiothixene, The risk or severity of QTc prolongation can be increased when Thiothixene is combined with Chloroquine.]
[C01BB04, aprindine, The metabolism of Aprindine can be decreased when combined with Chloroquine.]
[G04BE06, moxisylyte, Chloroquine may decrease the excretion rate of Moxisylyte which could result in a higher serum level.]
[N05AL03, tiapride, Chloroquine may decrease the excretion rate of Tiapride which could result in a higher serum level.]
[B01AC05, ticlopidine, The metabolism of Ticlopidine can be decreased when combined with Chloroquine.]
[S01ED01, timolol, The metabolism of Timolol can be decreased when combined with Chloroquine.]
[P01AB02, tinidazole, Chloroquine may decrease the excretion rate of Tinidazole which could result in a higher serum level.]
[S01AA12, tobramycin, Chloroquine may decrease the excretion rate of Tobramycin which could result in a higher serum level.]
[A10BB05, tolazamide, Chloroquine may decrease the excretion rate of Tolazamide which could result in a higher serum level.]
[V04CA01, tolbutamide, The metabolism of Tolbutamide can be decreased when combined with Chloroquine.]
[M02AA21, tolmetin, Tolmetin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N02AX02, tramadol, The metabolism of Tramadol can be decreased when combined with Chloroquine.]
[N06AF04, tranylcypromine, The metabolism of Chloroquine can be decreased when combined with Tranylcypromine.]
[N06AX05, trazodone, The risk or severity of QTc prolongation can be increased when Trazodone is combined with Chloroquine.]
[L01XF01, tretinoin, The metabolism of Tretinoin can be decreased when combined with Chloroquine.]
[S01BA05, triamcinolone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Triamcinolone.]
[C03DB02, triamterene, Triamterene may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CD05, triazolam, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Triazolam.]
[C03AA06, trichlormethiazide, Trichlormethiazide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AX12, trientine, Chloroquine may decrease the excretion rate of Triethylenetetramine which could result in a higher serum level.]
[N05AB06, trifluoperazine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Trifluoperazine.]
[S01AD02, trifluridine, Trifluridine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N05AA05, triflupromazine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Triflupromazine.]
[R03BA07, mometasone, The metabolism of Chloroquine can be increased when combined with Mometasone.]
[A03AA05, trimebutine, The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Chloroquine.]
[R06AD01, trimeprazine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Alimemazine.]
[N03AC02, trimethadione, The metabolism of Chloroquine can be decreased when combined with Trimethadione.]
[C02BA01, trimethaphan, The risk or severity of adverse effects can be increased when Chloroquine is combined with Trimethaphan.]
[J01EA01, trimethoprim, The metabolism of Chloroquine can be decreased when combined with Trimethoprim.]
[N06AA06, trimipramine, The metabolism of Trimipramine can be decreased when combined with Chloroquine.]
[R06AC04, tripelennamine, The metabolism of Chloroquine can be decreased when combined with Tripelennamine.]
[R06AX07, triprolidine, The risk or severity of QTc prolongation can be increased when Triprolidine is combined with Chloroquine.]
[J01FA08, troleandomycin, The metabolism of Chloroquine can be decreased when combined with Troleandomycin.]
[N06AX24, vilazodone, The metabolism of Vilazodone can be decreased when combined with Chloroquine.]
[M03AA02, tubocurarine, The therapeutic efficacy of Tubocurarine can be increased when used in combination with Chloroquine.]
[R03DX07, roflumilast, Chloroquine may decrease the excretion rate of Roflumilast which could result in a higher serum level.]
[L01FX04, ipilimumab, Chloroquine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.]
[L01EX04, vandetanib, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Vandetanib.]
[R02AA14, oxyquinoline, Chloroquine may decrease the excretion rate of Oxyquinoline which could result in a higher serum level.]
[L02BX03, abiraterone, The metabolism of Chloroquine can be decreased when combined with Abiraterone.]
[A10BH05, linagliptin, The metabolism of Chloroquine can be decreased when combined with Linagliptin.]
[J05AP03, boceprevir, The metabolism of Chloroquine can be decreased when combined with Boceprevir.]
[J05AP02, telaprevir, The metabolism of Chloroquine can be decreased when combined with Telaprevir.]
[J05AG05, rilpivirine, The metabolism of Chloroquine can be decreased when combined with Rilpivirine.]
[S01AA28, vancomycin, Chloroquine may decrease the excretion rate of Vancomycin which could result in a higher serum level.]
[N03AX21, ezogabine, The therapeutic efficacy of Ezogabine can be decreased when used in combination with Chloroquine.]
[B01AF01, rivaroxaban, Chloroquine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.]
[R03AC18, indacaterol, The risk or severity of QTc prolongation can be increased when Indacaterol is combined with Chloroquine.]
[B01AC24, ticagrelor, The metabolism of Ticagrelor can be decreased when combined with Chloroquine.]
[C08DA01, verapamil, The metabolism of Chloroquine can be decreased when combined with Verapamil.]
[N06AX09, viloxazine, The metabolism of Chloroquine can be decreased when combined with Viloxazine.]
[L01CA01, vinblastine, The metabolism of Chloroquine can be decreased when combined with Vinblastine.]
[L01CA02, vincristine, The metabolism of Vincristine can be decreased when combined with Chloroquine.]
[B03BA01, vitamin B12, Cyanocobalamin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[B01AA03, warfarin, Chloroquine may decrease the excretion rate of Warfarin which could result in a higher serum level.]
[C03BA10, xipamide, Xipamide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF01, zidovudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Zidovudine is combined with Chloroquine.]
[N05AF05, zuclopenthixol, The metabolism of Zuclopenthixol can be decreased when combined with Chloroquine.]
[J05AE02, indinavir, The metabolism of Chloroquine can be decreased when combined with Indinavir.]
[N03AX14, levetiracetam, The therapeutic efficacy of Levetiracetam can be decreased when used in combination with Chloroquine.]
[L01EC01, vemurafenib, The risk or severity of QTc prolongation can be increased when Vemurafenib is combined with Chloroquine.]
[M05BA03, pamidronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pamidronic acid is combined with Chloroquine.]
[M05BA05, tiludronic acid, Chloroquine may decrease the excretion rate of Tiludronic acid which could result in a higher serum level.]
[B06AC02, icatibant, Chloroquine may decrease the excretion rate of Icatibant which could result in a higher serum level.]
[L01ED01, crizotinib, The metabolism of Crizotinib can be decreased when combined with Chloroquine.]
[A02BC04, rabeprazole, Chloroquine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[M05BA06, ibandronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Ibandronate.]
[J01MA13, trovafloxacin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Trovafloxacin.]
[N05AE04, ziprasidone, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Ziprasidone.]
[G03AC10, drospirenone, Drospirenone may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AC02, deferiprone, Chloroquine may decrease the excretion rate of Deferiprone which could result in a higher serum level.]
[N02BA01, aspirin, Acetylsalicylic acid may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EJ01, ruxolitinib, Chloroquine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.]
[G04BD07, tolterodine, The metabolism of Tolterodine can be decreased when combined with Chloroquine.]
[J01DH04, doripenem, Chloroquine may decrease the excretion rate of Doripenem which could result in a higher serum level.]
[C07AB03, atenolol, The metabolism of Atenolol can be decreased when combined with Chloroquine.]
[J02AC03, voriconazole, The metabolism of Chloroquine can be decreased when combined with Voriconazole.]
[M03AC04, atracurium, The therapeutic efficacy of Atracurium can be increased when used in combination with Chloroquine.]
[S01FA01, atropine, The risk or severity of QTc prolongation can be increased when Atropine is combined with Chloroquine.]
[M01CB03, auranofin, Chloroquine may decrease the excretion rate of Auranofin which could result in a higher serum level.]
[L01EK01, axitinib, The metabolism of Axitinib can be decreased when combined with Chloroquine.]
[R07AX02, ivacaftor, The metabolism of Ivacaftor can be decreased when combined with Chloroquine.]
[H02AB11, prednylidene, The metabolism of Chloroquine can be increased when combined with Prednylidene.]
[B03XA04, peginesatide, Chloroquine may decrease the excretion rate of Peginesatide which could result in a higher serum level.]
[L01BC07, azacitidine, Chloroquine may decrease the excretion rate of Azacitidine which could result in a higher serum level.]
[L04AX01, azathioprine, Chloroquine may decrease the excretion rate of Azathioprine which could result in a higher serum level.]
[L01BC05, gemcitabine, Gemcitabine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DF01, aztreonam, Aztreonam may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[R02AB04, bacitracin, Bacitracin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[G04BE10, avanafil, The serum concentration of Avanafil can be increased when it is combined with Chloroquine.]
[M03BX01, baclofen, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Baclofen is combined with Chloroquine.]
[A08AA11, lorcaserin, The metabolism of Lorcaserin can be decreased when combined with Chloroquine.]
[G04BD12, mirabegron, The serum concentration of Chloroquine can be increased when it is combined with Mirabegron.]
[V03AX03, cobicistat, The metabolism of Chloroquine can be decreased when combined with Cobicistat.]
[J05AJ02, elvitegravir, The metabolism of Chloroquine can be decreased when combined with Elvitegravir.]
[L02BB04, enzalutamide, The serum concentration of Chloroquine can be decreased when it is combined with Enzalutamide.]
[L01EA04, bosutinib, The metabolism of Chloroquine can be decreased when combined with Bosutinib.]
[L04AA31, teriflunomide, The metabolism of Chloroquine can be decreased when combined with Teriflunomide.]
[A02AA05, magnesium silicate, Magnesium silicate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AC02, calcium silicate, Calcium silicate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N05CA04, barbital, The therapeutic efficacy of Barbital can be decreased when used in combination with Chloroquine.]
[C01AA01, acetyldigitoxin, The serum concentration of Acetyldigitoxin can be increased when it is combined with Chloroquine.]
[D02BA02, octinoxate, Chloroquine may decrease the excretion rate of Octinoxate which could result in a higher serum level.]
[J05AE04, nelfinavir, The metabolism of Chloroquine can be decreased when combined with Nelfinavir.]
[N04BD02, rasagiline, Chloroquine may decrease the excretion rate of Rasagiline which could result in a higher serum level.]
[C08CA13, lercanidipine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Lercanidipine is combined with Chloroquine.]
[N06DA02, donepezil, The metabolism of Donepezil can be decreased when combined with Chloroquine.]
[N03AX22, perampanel, The therapeutic efficacy of Perampanel can be decreased when used in combination with Chloroquine.]
[G04BD10, darifenacin, The metabolism of Chloroquine can be decreased when combined with Darifenacin.]
[V09IX04, fluorodeoxyglucose F18, Chloroquine may decrease the excretion rate of Fludeoxyglucose (18F) which could result in a higher serum level.]
[L01EX07, cabozantinib, The metabolism of Chloroquine can be decreased when combined with Cabozantinib.]
[H01CB05, pasireotide, The risk or severity of QTc prolongation can be increased when Pasireotide is combined with Chloroquine.]
[G04BE03, sildenafil, The metabolism of Sildenafil can be decreased when combined with Chloroquine.]
[V08CA11, gadofosveset, Chloroquine may decrease the excretion rate of Gadofosveset trisodium which could result in a higher serum level.]
[L01EA05, ponatinib, The metabolism of Ponatinib can be decreased when combined with Chloroquine.]
[B01AF02, apixaban, The metabolism of Apixaban can be decreased when combined with Chloroquine.]
[A16AX08, teduglutide, Chloroquine may decrease the excretion rate of Teduglutide which could result in a higher serum level.]
[J04AK05, bedaquiline, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Bedaquiline.]
[C04AX11, bencyclane, The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Chloroquine.]
[A10BH04, alogliptin, The metabolism of Alogliptin can be decreased when combined with Chloroquine.]
[A16AX09, glycerol phenylbutyrate, The metabolism of Chloroquine can be decreased when combined with Glycerol phenylbutyrate.]
[C03AA01, bendroflumethiazide, Bendroflumethiazide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[L04AX06, pomalidomide, Chloroquine may decrease the excretion rate of Pomalidomide which could result in a higher serum level.]
[G03XC05, ospemifene, The metabolism of Chloroquine can be decreased when combined with Ospemifene.]
[N02BA10, benorilate, Benorilate may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[A10BK02, canagliflozin, Canagliflozin may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01MA15, gemifloxacin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Gemifloxacin.]
[A12CC09, magnesium orotate, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Magnesium orotate.]
[S01AE07, moxifloxacin, The risk or severity of QTc prolongation can be increased when Moxifloxacin is combined with Chloroquine.]
[A06AX06, tegaserod, The metabolism of Tegaserod can be decreased when combined with Chloroquine.]
[R02AD01, benzocaine, The metabolism of Benzocaine can be decreased when combined with Chloroquine.]
[L03AA12, ancestim, Chloroquine may decrease the excretion rate of Ancestim which could result in a higher serum level.]
[M01AH01, celecoxib, The metabolism of Chloroquine can be decreased when combined with Celecoxib.]
[L04AA18, everolimus, The metabolism of Chloroquine can be decreased when combined with Everolimus.]
[A12CC05, magnesium aspartate, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Magnesium aspartate.]
[N04AC01, benztropine, The metabolism of Benzatropine can be decreased when combined with Chloroquine.]
[L01EC02, dabrafenib, The serum concentration of Chloroquine can be decreased when it is combined with Dabrafenib.]
[R02AX03, benzydamine, Benzydamine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EE01, trametinib, The metabolism of Chloroquine can be decreased when combined with Trametinib.]
[P03AX06, benzyl alcohol, The metabolism of Benzyl alcohol can be decreased when combined with Chloroquine.]
[V09AX05, florbetapir F-18, Chloroquine may decrease the excretion rate of Florbetapir (18F) which could result in a higher serum level.]
[N06AX28, levomilnacipran, The metabolism of Levomilnacipran can be decreased when combined with Chloroquine.]
[C08EA02, bepridil, The metabolism of Bepridil can be decreased when combined with Chloroquine.]
[C02KX05, riociguat, The metabolism of Riociguat can be decreased when combined with Chloroquine.]
[A10BJ03, lixisenatide, Chloroquine may decrease the excretion rate of Lixisenatide which could result in a higher serum level.]
[C02KX04, macitentan, Chloroquine may decrease the excretion rate of Macitentan which could result in a higher serum level.]
[L01EL01, ibrutinib, The metabolism of Ibrutinib can be decreased when combined with Chloroquine.]
[N06AX26, vortioxetine, The metabolism of Vortioxetine can be decreased when combined with Chloroquine.]
[G03AC08, etonogestrel, Etonogestrel may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N03AF04, eslicarbazepine, The therapeutic efficacy of Eslicarbazepine can be decreased when used in combination with Chloroquine.]
[J05AP05, simeprevir, The metabolism of Chloroquine can be decreased when combined with Simeprevir.]
[J05AP08, sofosbuvir, Chloroquine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.]
[N03AG04, vigabatrin, The therapeutic efficacy of Vigabatrin can be decreased when used in combination with Chloroquine.]
[A10BK01, dapagliflozin, The metabolism of Dapagliflozin can be decreased when combined with Chloroquine.]
[C01CA27, droxidopa, Chloroquine may decrease the excretion rate of Droxidopa which could result in a higher serum level.]
[C07AB04, acebutolol, The metabolism of Acebutolol can be decreased when combined with Chloroquine.]
[N05CH03, tasimelteon, Chloroquine may decrease the excretion rate of Tasimelteon which could result in a higher serum level.]
[A16AA07, metreleptin, The metabolism of Chloroquine can be increased when combined with Metreleptin.]
[L04AA32, apremilast, The metabolism of Chloroquine can be increased when combined with Apremilast.]
[L02BG02, formestane, Chloroquine may decrease the excretion rate of Formestane which could result in a higher serum level.]
[S03BA03, betamethasone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Betamethasone is combined with Chloroquine.]
[S01ED02, betaxolol, The metabolism of Betaxolol can be decreased when combined with Chloroquine.]
[V03AB34, fomepizole, Chloroquine may decrease the excretion rate of Fomepizole which could result in a higher serum level.]
[C10AB02, bezafibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Bezafibrate.]
[L04AC11, siltuximab, The metabolism of Chloroquine can be increased when combined with Siltuximab.]
[L01ED02, ceritinib, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Ceritinib.]
[A03BA03, hyoscyamine, The risk or severity of QTc prolongation can be increased when Hyoscyamine is combined with Chloroquine.]
[R03AC19, olodaterol, The metabolism of Olodaterol can be decreased when combined with Chloroquine.]
[V08AA01, diatrizoic acid, Diatrizoate may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[V08AA04, iothalamic acid, Diatrizoate may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[A16AX10, eliglustat, The metabolism of Chloroquine can be decreased when combined with Eliglustat.]
[J01XA05, oritavancin, The metabolism of Chloroquine can be decreased when combined with Oritavancin.]
[S01AA15, dihydrostreptomycin, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Dihydrostreptomycin.]
[N05AA04, acepromazine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Acepromazine.]
[N04AA02, biperiden, The metabolism of Chloroquine can be decreased when combined with Biperiden.]
[L04AX05, pirfenidone, The metabolism of Pirfenidone can be decreased when combined with Chloroquine.]
[S03AA06, gentamicin, Chloroquine may decrease the excretion rate of Gentamicin which could result in a higher serum level.]
[J05AP09, dasabuvir, The metabolism of Dasabuvir can be decreased when combined with Chloroquine.]
[L01XK01, olaparib, The metabolism of Olaparib can be decreased when combined with Chloroquine.]
[B01AF03, edoxaban, Chloroquine may decrease the excretion rate of Edoxaban which could result in a higher serum level.]
[N06AX11, mirtazapine, The metabolism of Mirtazapine can be decreased when combined with Chloroquine.]
[L04AC10, secukinumab, The metabolism of Chloroquine can be increased when combined with Secukinumab.]
[L01EX08, lenvatinib, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Lenvatinib.]
[L01XH03, panobinostat, The metabolism of Chloroquine can be decreased when combined with Panobinostat.]
[J05AP07, daclatasvir, The metabolism of Daclatasvir can be decreased when combined with Chloroquine.]
[N02BE01, acetaminophen, The metabolism of Acetaminophen can be decreased when combined with Chloroquine.]
[L01DC01, bleomycin, Bleomycin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C01EB17, ivabradine, Ivabradine may increase the QTc-prolonging activities of Chloroquine.]
[J05AF08, adefovir dipivoxil, Adefovir dipivoxil may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J05AP06, asunaprevir, The metabolism of Asunaprevir can be decreased when combined with Chloroquine.]
[N05AX16, brexpiprazole, The metabolism of Brexpiprazole can be decreased when combined with Chloroquine.]
[A04AD14, rolapitant, The metabolism of Chloroquine can be decreased when combined with Rolapitant.]
[A06AD03, magnesium peroxide, Magnesium peroxide can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[M02AA25, aceclofenac, Aceclofenac may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[M01AB11, acemetacin, Acemetacin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[S01EC01, acetazolamide, Acetazolamide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AB07, acetophenazine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Acetophenazine.]
[C10AD06, acipimox, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Acipimox.]
[A02BC03, lansoprazole, The metabolism of Chloroquine can be decreased when combined with Lansoprazole.]
[V03AB37, idarucizumab, Chloroquine may decrease the excretion rate of Idarucizumab which could result in a higher serum level.]
[L01CX01, trabectedin, The metabolism of Trabectedin can be decreased when combined with Chloroquine.]
[J02AC05, isavuconazole, The metabolism of Chloroquine can be decreased when combined with Isavuconazole.]
[J05AF13, tenofovir alafenamide, The serum concentration of Tenofovir alafenamide can be increased when it is combined with Chloroquine.]
[L01XG03, ixazomib, Chloroquine may decrease the excretion rate of Ixazomib which could result in a higher serum level.]
[B01AC27, selexipag, The metabolism of Selexipag can be decreased when combined with Chloroquine.]
[G04CA01, alfuzosin, The risk or severity of QTc prolongation can be increased when Alfuzosin is combined with Chloroquine.]
[M04AB05, lesinurad, Chloroquine may decrease the excretion rate of Lesinurad which could result in a higher serum level.]
[J05AP10, elbasvir, The metabolism of Elbasvir can be decreased when combined with Chloroquine.]
[M01AE16, alminoprofen, Alminoprofen may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[A02AB06, aloglutamol, Aloglutamol can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N03AX23, brivaracetam, The therapeutic efficacy of Brivaracetam can be decreased when used in combination with Chloroquine.]
[L01XX52, venetoclax, The metabolism of Chloroquine can be decreased when combined with Venetoclax.]
[N05BA08, bromazepam, Chloroquine may decrease the excretion rate of Bromazepam which could result in a higher serum level.]
[A02AD05, aluminum magnesium silicate, Almasilate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A02AB03, aluminum phosphate, Aluminium phosphate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[R06AB01, brompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Chloroquine.]
[C03CA02, bumetanide, Bumetanide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N01BB01, bupivacaine, The metabolism of Bupivacaine can be decreased when combined with Chloroquine.]
[C07AA19, bupranolol, The metabolism of Bupranolol can be decreased when combined with Chloroquine.]
[N07BC01, buprenorphine, The metabolism of Buprenorphine can be decreased when combined with Chloroquine.]
[L02AE01, buserelin, The risk or severity of QTc prolongation can be increased when Buserelin is combined with Chloroquine.]
[N05BE01, buspirone, The metabolism of Buspirone can be decreased when combined with Chloroquine.]
[L01XX27, arsenic trioxide, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Arsenic trioxide.]
[P01BE02, artemether, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Artemether.]
[M02AA03, clofezone, Chloroquine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.]
[J01MA09, sparfloxacin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Sparfloxacin.]
[R06AX09, azatadine, The risk or severity of QTc prolongation can be increased when Azatadine is combined with Chloroquine.]
[S01GX07, azelastine, The metabolism of Azelastine can be decreased when combined with Chloroquine.]
[L01XK03, rucaparib, The metabolism of Rucaparib can be decreased when combined with Chloroquine.]
[S01AA26, azithromycin, The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Chloroquine.]
[L01EF02, ribociclib, The metabolism of Chloroquine can be decreased when combined with Ribociclib.]
[A07EC04, balsalazide, Balsalazide may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[A06AH05, naldemedine, Chloroquine may decrease the excretion rate of Naldemedine which could result in a higher serum level.]
[N07XX16, deutetrabenazine, The metabolism of Deutetrabenazine can be decreased when combined with Chloroquine.]
[N02BF02, pregabalin, The therapeutic efficacy of Pregabalin can be decreased when used in combination with Chloroquine.]
[N03AX30, beclamide, The therapeutic efficacy of Beclamide can be decreased when used in combination with Chloroquine.]
[S01HA02, benoxinate, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Oxybuprocaine.]
[A12AA04, calcium carbonate, Calcium carbonate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[P01CA02, benznidazole, Chloroquine may decrease the excretion rate of Benznidazole which could result in a higher serum level.]
[J05AF06, abacavir, Chloroquine may decrease the excretion rate of Abacavir which could result in a higher serum level.]
[J05AE09, tipranavir, The metabolism of Chloroquine can be decreased when combined with Tipranavir.]
[N07XX13, valbenazine, The metabolism of Valbenazine can be decreased when combined with Chloroquine.]
[L04AB02, infliximab, The metabolism of Chloroquine can be increased when combined with Infliximab.]
[L01EX10, midostaurin, The metabolism of Chloroquine can be decreased when combined with Midostaurin.]
[L01ED04, brigatinib, The metabolism of Brigatinib can be decreased when combined with Chloroquine.]
[J01MA23, delafloxacin, The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Chloroquine.]
[L01BC06, capecitabine, Chloroquine may decrease the excretion rate of Capecitabine which could result in a higher serum level.]
[L01XX59, enasidenib, The metabolism of Enasidenib can be decreased when combined with Chloroquine.]
[L01XH01, vorinostat, The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Chloroquine.]
[L01EM02, copanlisib, The metabolism of Copanlisib can be decreased when combined with Chloroquine.]
[A02BX12, bismuth subnitrate, Bismuth subnitrate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[C07AB07, bisoprolol, The risk or severity of QTc prolongation can be decreased when Chloroquine is combined with Bisoprolol.]
[J05AG03, efavirenz, The metabolism of Chloroquine can be decreased when combined with Efavirenz.]
[J01DC10, cefprozil, Cefprozil may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C07AA17, bopindolol, The metabolism of Bopindolol can be decreased when combined with Chloroquine.]
[C03DA03, canrenone, Canrenone may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[R03BA02, budesonide, The metabolism of Chloroquine can be increased when combined with Budesonide.]
[M01AB07, bumadizone, Bumadizone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EL02, acalabrutinib, The metabolism of Chloroquine can be decreased when combined with Acalabrutinib.]
[J05AX18, letermovir, The metabolism of Letermovir can be decreased when combined with Chloroquine.]
[N06AA15, butriptyline, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Butriptyline.]
[C01AA02, acetyldigoxins, The serum concentration of Acetyldigoxin can be increased when it is combined with Chloroquine.]
[N01BX04, capsaicin, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Capsaicin.]
[A10BK04, ertugliflozin, Ertugliflozin may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AX18, acrivastine, The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Chloroquine.]
[C09AA01, captopril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Captopril.]
[V04CD06, macimorelin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Macimorelin.]
[L02BB05, apalutamide, The metabolism of Chloroquine can be increased when combined with Apalutamide.]
[N03AF01, carbamazepine, The metabolism of Carbamazepine can be decreased when combined with Chloroquine.]
[H03BB01, carbimazole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Carbimazole is combined with Chloroquine.]
[R06AA08, carbinoxamine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Carbinoxamine.]
[C07AG02, carvedilol, The metabolism of Carvedilol can be decreased when combined with Chloroquine.]
[N03AX24, cannabidiol, The metabolism of Chloroquine can be decreased when combined with Cannabidiol.]
[B02BX08, avatrombopag, The metabolism of Chloroquine can be increased when combined with Avatrombopag.]
[L04AA37, baricitinib, Chloroquine may decrease the excretion rate of Baricitinib which could result in a higher serum level.]
[J01DE01, cefepime, Cefepime may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DD10, cefetamet, Cefetamet may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DD09, cefodizime, Cefodizime may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DC11, ceforanide, Ceforanide may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DD13, cefpodoxime, Cefpodoxime may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EC03, encorafenib, The metabolism of Encorafenib can be decreased when combined with Chloroquine.]
[J01DD14, ceftibuten, Ceftibuten may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01GB14, plazomicin, Chloroquine may decrease the excretion rate of Plazomicin which could result in a higher serum level.]
[C07AB08, celiprolol, The metabolism of Celiprolol can be decreased when combined with Chloroquine.]
[H01CC03, elagolix, The metabolism of Elagolix can be decreased when combined with Chloroquine.]
[L01XX62, ivosidenib, The metabolism of Chloroquine can be increased when combined with Ivosidenib.]
[P01BA07, tafenoquine, The metabolism of Tafenoquine can be decreased when combined with Chloroquine.]
[A16AX14, migalastat, Chloroquine may decrease the excretion rate of Migalastat which could result in a higher serum level.]
[N03AX17, stiripentol, The metabolism of Chloroquine can be decreased when combined with Stiripentol.]
[J05AX24, tecovirimat, The metabolism of Chloroquine can be increased when combined with Tecovirimat.]
[J05AG06, doravirine, The metabolism of Doravirine can be decreased when combined with Chloroquine.]
[L01EB07, dacomitinib, The metabolism of Dacomitinib can be decreased when combined with Chloroquine.]
[S01GX12, cetirizine, The risk or severity of QTc prolongation can be increased when Cetirizine is combined with Chloroquine.]
[N01BA04, chloroprocaine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Chloroprocaine.]
[D08AE05, chloroxylenol, Chloroquine may decrease the excretion rate of Chloroxylenol which could result in a higher serum level.]
[M01AC05, lornoxicam, Lornoxicam may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N07XX15, inotersen, The risk or severity of QTc prolongation can be increased when Inotersen is combined with Chloroquine.]
[R03BB08, revefenacin, The metabolism of Revefenacin can be decreased when combined with Chloroquine.]
[L01ED05, lorlatinib, The metabolism of Lorlatinib can be decreased when combined with Chloroquine.]
[L04AA39, emapalumab, The metabolism of Chloroquine can be increased when combined with Emapalumab.]
[L01AD01, carmustine, Carmustine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EX13, gilteritinib, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Gilteritinib.]
[L01XJ03, glasdegib, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Glasdegib.]
[N07XX05, amifampridine, The risk or severity of seizure can be increased when Chloroquine is combined with Amifampridine.]
[A06AX05, prucalopride, Chloroquine may decrease the excretion rate of Prucalopride which could result in a higher serum level.]
[C01BG07, cifenline, The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Chloroquine.]
[B01AC23, cilostazol, The metabolism of Cilostazol can be decreased when combined with Chloroquine.]
[C10AB08, ciprofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Ciprofibrate.]
[P02BX04, triclabendazole, The metabolism of Triclabendazole can be decreased when combined with Chloroquine.]
[J01FA09, clarithromycin, The metabolism of Chloroquine can be decreased when combined with Clarithromycin.]
[N06BA14, solriamfetol, Chloroquine may decrease the excretion rate of Solriamfetol which could result in a higher serum level.]
[N06AX29, brexanolone, The therapeutic efficacy of Brexanolone can be decreased when used in combination with Chloroquine.]
[N05BA09, clobazam, The metabolism of Chloroquine can be decreased when combined with Clobazam.]
[J01AA11, clomocycline, The risk or severity of neuromuscular blockade can be increased when Clomocycline is combined with Chloroquine.]
[H02AB14, cloprednol, The metabolism of Chloroquine can be increased when combined with Cloprednol.]
[C01EB09, ubidecarenone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Ubidecarenone.]
[C09CA06, candesartan, The metabolism of Chloroquine can be decreased when combined with Candesartan.]
[L04AB01, etanercept, The metabolism of Chloroquine can be increased when combined with Etanercept.]
[H02AB17, cortivazol, The metabolism of Chloroquine can be increased when combined with Cortivazol.]
[L01EM03, alpelisib, The metabolism of Chloroquine can be decreased when combined with Alpelisib.]
[J01DC04, cefaclor, Cefaclor may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DB05, cefadroxil, Cefadroxil may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DC03, cefamandole, Cefamandole may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DB07, cefatrizine, Cefatrizine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DB04, cefazolin, Cefazolin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DC09, cefmetazole, Cefmetazole may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DC06, cefonicid, Cefonicid may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DD12, cefoperazone, Cefoperazone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DD01, cefotaxime, Cefotaxime may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DC05, cefotetan, Cefotetan may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N05AA06, cyamemazine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Cyamemazine.]
[J01DC07, cefotiam, Cefotiam may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DC01, cefoxitin, Cefoxitin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DD03, cefsulodin, Cefsulodin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DD02, ceftazidime, Ceftazidime may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C03BX03, cicletanine, Cicletanine may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01DD07, ceftizoxime, Ceftizoxime may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DD04, ceftriaxone, Ceftriaxone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[S01AA27, cefuroxime, Cefuroxime may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EJ02, fedratinib, The metabolism of Chloroquine can be decreased when combined with Fedratinib.]
[L01EX14, entrectinib, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Entrectinib.]
[N07XX11, pitolisant, The serum concentration of Chloroquine can be decreased when it is combined with Pitolisant.]
[J01XX12, lefamulin, Lefamulin may increase the QTc-prolonging activities of Chloroquine.]
[N04CX01, istradefylline, The metabolism of Istradefylline can be decreased when combined with Chloroquine.]
[C03AA09, cyclothiazide, Cyclothiazide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[G04BE04, yohimbine, The metabolism of Yohimbine can be decreased when combined with Chloroquine.]
[J01XX09, daptomycin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Daptomycin is combined with Chloroquine.]
[J01DB01, cephalexin, Cephalexin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DB02, cephaloridine, Cefaloridine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DB03, cephalothin, Cefalotin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DB08, cephapirin, Cefapirin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DB09, cephradine, Cefradine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01FD03, ado-trastuzumab emtansine, The metabolism of Trastuzumab emtansine can be decreased when combined with Chloroquine.]
[N03AX25, cenobamate, The serum concentration of Chloroquine can be decreased when it is combined with Cenobamate.]
[A16AX16, givosiran, The serum concentration of Chloroquine can be increased when it is combined with Givosiran.]
[M09AX08, golodirsen, Chloroquine may decrease the excretion rate of Golodirsen which could result in a higher serum level.]
[R06AB06, dexbrompheniramine, The risk or severity of QTc prolongation can be increased when Dexbrompheniramine is combined with Chloroquine.]
[R06AB02, dexchlorpheniramine, The metabolism of Dexchlorpheniramine can be decreased when combined with Chloroquine.]
[S01XA12, dexpanthenol, Chloroquine may decrease the excretion rate of Dexpanthenol which could result in a higher serum level.]
[N05CM21, lemborexant, The metabolism of Lemborexant can be decreased when combined with Chloroquine.]
[M01AX21, diacetylrhein, The metabolism of Chloroquine can be decreased when combined with Diacerein.]
[J05AB16, remdesivir, The therapeutic efficacy of Remdesivir can be decreased when used in combination with Chloroquine.]
[S01AE06, gatifloxacin, The risk or severity of QTc prolongation can be increased when Gatifloxacin is combined with Chloroquine.]
[H02CA02, osilodrostat, The metabolism of Chloroquine can be decreased when combined with Osilodrostat.]
[J05AE05, amprenavir, The metabolism of Chloroquine can be decreased when combined with Amprenavir.]
[G04CB02, dutasteride, The metabolism of Dutasteride can be decreased when combined with Chloroquine.]
[L04AA38, ozanimod, The metabolism of Ozanimod can be decreased when combined with Chloroquine.]
[L01EE04, selumetinib, The metabolism of Selumetinib can be decreased when combined with Chloroquine.]
[R02AA03, dichlorobenzyl alcohol, Chloroquine may decrease the excretion rate of Dichlorobenzyl alcohol which could result in a higher serum level.]
[G03DB08, dienogest, Chloroquine may decrease the excretion rate of Dienogest which could result in a higher serum level.]
[N02AA08, dihydrocodeine, The metabolism of Dihydrocodeine can be decreased when combined with Chloroquine.]
[N02CC06, eletriptan, The metabolism of Eletriptan can be decreased when combined with Chloroquine.]
[M01AH02, rofecoxib, Rofecoxib may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01XF03, bexarotene, The metabolism of Chloroquine can be decreased when combined with Bexarotene.]
[C08CA16, clevidipine, The metabolism of Clevidipine can be decreased when combined with Chloroquine.]
[C01BD07, dronedarone, The metabolism of Chloroquine can be decreased when combined with Dronedarone.]
[N03AG02, dipropylacetamide, The therapeutic efficacy of Valpromide can be decreased when used in combination with Chloroquine.]
[V03AE03, lanthanum carbonate, Lanthanum carbonate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[S03AA08, chloramphenicol, The metabolism of Chloroquine can be decreased when combined with Chloramphenicol.]
[R06AE04, chlorcyclizine, The risk or severity of QTc prolongation can be increased when Chlorcyclizine is combined with Chloroquine.]
[L01EH03, tucatinib, The metabolism of Tucatinib can be decreased when combined with Chloroquine.]
[D07XB03, fluprednidene, The metabolism of Chloroquine can be increased when combined with Fluprednidene.]
[G04BD09, trospium, The metabolism of Chloroquine can be decreased when combined with Trospium.]
[M01AC04, droxicam, Droxicam may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[V08CA05, mangafodipir, Chloroquine may decrease the excretion rate of Mangafodipir which could result in a higher serum level.]
[L01EX22, selpercatinib, The serum concentration of Chloroquine can be increased when it is combined with Selpercatinib.]
[M02AA27, dexketoprofen, Dexketoprofen may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N05CM02, chlormethiazole, The therapeutic efficacy of Clomethiazole can be decreased when used in combination with Chloroquine.]
[R02AD04, dyclonine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Dyclonine.]
[C08CA17, levamlodipine, The metabolism of Levamlodipine can be decreased when combined with Chloroquine.]
[R06AX22, ebastine, The risk or severity of QTc prolongation can be increased when Ebastine is combined with Chloroquine.]
[J05AX29, fostemsavir, The risk or severity of QTc prolongation can be increased when Fostemsavir is combined with Chloroquine.]
[P01BB01, proguanil, The metabolism of Chloroquine can be decreased when combined with Proguanil.]
[L04AC19, satralizumab, The serum concentration of Chloroquine can be decreased when it is combined with Satralizumab.]
[N02AX07, oliceridine, The serum concentration of Oliceridine can be increased when it is combined with Chloroquine.]
[S01AA13, fusidic acid, The metabolism of Fusidic acid can be decreased when combined with Chloroquine.]
[J01MB04, pipemidic acid, The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Chloroquine.]
[L01EX23, pralsetinib, The metabolism of Chloroquine can be decreased when combined with Pralsetinib.]
[C03AA04, chlorothiazide, Chlorothiazide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[R06AB04, chlorpheniramine, The metabolism of Chlorpheniramine can be decreased when combined with Chloroquine.]
[N05AA01, chlorpromazine, The metabolism of Chloroquine can be decreased when combined with Chlorpromazine.]
[A10BB02, chlorpropamide, Chloroquine may decrease the excretion rate of Chlorpropamide which could result in a higher serum level.]
[N05AF03, chlorprothixene, The risk or severity of QTc prolongation can be increased when Chlorprothixene is combined with Chloroquine.]
[C03BA04, chlorthalidone, Chlorthalidone may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[M03BB03, chlorzoxazone, The metabolism of Chlorzoxazone can be decreased when combined with Chloroquine.]
[A11CC05, cholecalciferol, The metabolism of Chloroquine can be decreased when combined with Cholecalciferol.]
[N02BA07, ethenzamide, Ethenzamide may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N06BX18, vinpocetine, The therapeutic efficacy of Vinpocetine can be decreased when used in combination with Chloroquine.]
[M01AB08, etodolac, Etodolac may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[M02AA06, etofenamate, Etofenamate may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C10AB09, etofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Etofibrate.]
[B06AC06, berotralstat, The metabolism of Chloroquine can be decreased when combined with Berotralstat.]
[A16AX20, lonafarnib, The metabolism of Chloroquine can be decreased when combined with Lonafarnib.]
[L02BX04, relugolix, The risk or severity of QTc prolongation can be increased when Relugolix is combined with Chloroquine.]
[M01AX25, chondroitin sulfates, Chloroquine may decrease the excretion rate of Chondroitin sulfate which could result in a higher serum level.]
[P03AX07, abametapir, The serum concentration of Chloroquine can be increased when it is combined with Abametapir.]
[N03AX10, felbamate, The therapeutic efficacy of Felbamate can be decreased when used in combination with Chloroquine.]
[M01AE05, fenbufen, Fenbufen may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C01CA19, fenoldopam, Chloroquine may decrease the excretion rate of Fenoldopam which could result in a higher serum level.]
[G04CB01, finasteride, The metabolism of Finasteride can be decreased when combined with Chloroquine.]
[J01DD15, cefdinir, Cefdinir may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01MB07, flumequine, The risk or severity of QTc prolongation can be increased when Flumequine is combined with Chloroquine.]
[S02BA08, fluocinolone acetonide, Fluocinolone acetonide may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N02BG07, flupirtine, Chloroquine may decrease the excretion rate of Flupirtine which could result in a higher serum level.]
[R03CC15, formoterol, The metabolism of Formoterol can be decreased when combined with Chloroquine.]
[L04AA50, ponesimod, The risk or severity of bradycardia can be increased when Ponesimod is combined with Chloroquine.]
[L03AB10, peginterferon alfa-2b, The metabolism of Chloroquine can be decreased when combined with Peginterferon alfa-2b.]
[A02BA01, cimetidine, The serum concentration of the active metabolites of Chloroquine can be increased when Chloroquine is used in combination with Cimetidine.]
[N02BF01, gabapentin, The therapeutic efficacy of Gabapentin can be decreased when used in combination with Chloroquine.]
[V08CA04, gadoteridol, Gadoteridol may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N07CA02, cinnarizine, The metabolism of Cinnarizine can be decreased when combined with Chloroquine.]
[J01MB06, cinoxacin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Cinoxacin.]
[L01XX73, sotorasib, The serum concentration of Chloroquine can be decreased when it is combined with Sotorasib.]
[S03AA07, ciprofloxacin, The risk or severity of QTc prolongation can be increased when Ciprofloxacin is combined with Chloroquine.]
[L01XA01, cisplatin, Chloroquine may decrease the excretion rate of Cisplatin which could result in a higher serum level.]
[N06AB04, citalopram, The metabolism of Citalopram can be decreased when combined with Chloroquine.]
[C03DA05, finerenone, Finerenone may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[P01CA03, fexinidazole, The risk or severity of adverse effects can be increased when Chloroquine is combined with Fexinidazole.]
[L01EB10, mobocertinib, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Mobocertinib.]
[R06AA04, clemastine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Clemastine.]
[M01AG01, mefenamic acid, Mefenamic acid may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01FF01, clindamycin, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Clindamycin.]
[N06AX25, St. John's wort extract, The metabolism of Chloroquine can be increased when combined with St. John's Wort.]
[L03AB15, ropeginterferon alfa-2b, The metabolism of Chloroquine can be decreased when combined with Ropeginterferon alfa-2b.]
[J04BA01, clofazimine, The metabolism of Chloroquine can be decreased when combined with Clofazimine.]
[C10AB01, clofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Clofibrate.]
[B06AX04, mitapivat, The metabolism of Chloroquine can be increased when combined with Mitapivat.]
[N01BB10, levobupivacaine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Levobupivacaine.]
[L01EJ03, pacritinib, The risk or severity of QTc prolongation can be increased when Pacritinib is combined with Chloroquine.]
[N06AA04, clomipramine, The metabolism of Clomipramine can be decreased when combined with Chloroquine.]
[N03AE01, clonazepam, The therapeutic efficacy of Clonazepam can be decreased when used in combination with Chloroquine.]
[S01EA04, clonidine, The metabolism of Clonidine can be decreased when combined with Chloroquine.]
[C01EB24, mavacamten, The serum concentration of Chloroquine can be decreased when it is combined with Mavacamten.]
[J05AH02, oseltamivir, Oseltamivir may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C03BA03, clopamide, Clopamide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[A02BC08, vonoprazan, The metabolism of Vonoprazan can be decreased when combined with Chloroquine.]
[H01CC04, linzagolix, The serum concentration of Chloroquine can be increased when it is combined with Linzagolix.]
[A04AA01, ondansetron, The metabolism of Ondansetron can be decreased when combined with Chloroquine.]
[A04AA02, granisetron, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Granisetron.]
[N05AH02, clozapine, The metabolism of Chloroquine can be decreased when combined with Clozapine.]
[J01GB12, arbekacin, Chloroquine may decrease the excretion rate of Arbekacin which could result in a higher serum level.]
[H01AC08, somatrogon, The metabolism of Chloroquine can be increased when combined with Somatrogon.]
[S02DA02, cocaine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Cocaine.]
[L04AC21, bimekizumab, The metabolism of Chloroquine can be increased when combined with Bimekizumab.]
[M01AX13, proquazone, Proquazone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[R05DA04, codeine, The metabolism of Codeine can be decreased when combined with Chloroquine.]
[M04AC01, colchicine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Colchicine.]
[J01XB01, colistin, Chloroquine may decrease the excretion rate of Colistin which could result in a higher serum level.]
[J01DE02, cefpirome, Cefpirome may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L04AA13, leflunomide, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Leflunomide.]
[A02AD04, hydrotalcite, Hydrotalcite can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[N01AB07, desflurane, The risk or severity of QTc prolongation can be increased when Desflurane is combined with Chloroquine.]
[A04AA03, tropisetron, Chloroquine may decrease the excretion rate of Tropisetron which could result in a higher serum level.]
[C04AX28, ifenprodil, The therapeutic efficacy of Ifenprodil can be decreased when used in combination with Chloroquine.]
[A10BX03, nateglinide, The metabolism of Nateglinide can be decreased when combined with Chloroquine.]
[N02BA16, imidazole-2-hydroxybenzoate, Imidazole salicylate may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01FA15, telithromycin, The metabolism of Chloroquine can be decreased when combined with Telithromycin.]
[R03BA08, ciclesonide, The metabolism of Ciclesonide can be decreased when combined with Chloroquine.]
[B01AC10, indobufen, Indobufen may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[R06AX27, desloratadine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Desloratadine.]
[J05AB14, valganciclovir, Chloroquine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.]
[C05BB03, invert sugar, Chloroquine may decrease the excretion rate of Invert sugar which could result in a higher serum level.]
[V08AB09, iodixanol, Chloroquine may decrease the excretion rate of Iodixanol which could result in a higher serum level.]
[V08AB05, iopromide, Chloroquine may decrease the excretion rate of Iopromide which could result in a higher serum level.]
[V08AB07, ioversol, Chloroquine may decrease the excretion rate of Ioversol which could result in a higher serum level.]
[V08AB12, ioxilan, Chloroquine may decrease the excretion rate of Ioxilan which could result in a higher serum level.]
[M01AH03, valdecoxib, Valdecoxib may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C01AA06, lanatoside C, The serum concentration of Lanatoside C can be increased when it is combined with Chloroquine.]
[A03AX10, isometheptene, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Isometheptene.]
[N02CC05, almotriptan, The metabolism of Almotriptan can be decreased when combined with Chloroquine.]
[M01AH04, parecoxib, Parecoxib may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J02AC02, itraconazole, The metabolism of Chloroquine can be decreased when combined with Itraconazole.]
[S01AD03, acyclovir, Acyclovir may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[S01GX06, emedastine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Emedastine.]
[N05BA10, ketazolam, Chloroquine may decrease the excretion rate of Ketazolam which could result in a higher serum level.]
[M01AA06, kebuzone, Kebuzone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01EA01, imatinib, The serum concentration of Chloroquine can be increased when it is combined with Imatinib.]
[J02AC04, posaconazole, The metabolism of Chloroquine can be decreased when combined with Posaconazole.]
[C08CA09, lacidipine, The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Chloroquine.]
[V03AF07, rasburicase, The risk or severity of methemoglobinemia can be increased when Rasburicase is combined with Chloroquine.]
[N03AX09, lamotrigine, The therapeutic efficacy of Lamotrigine can be decreased when used in combination with Chloroquine.]
[S01GX02, levocabastine, The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Chloroquine.]
[H01CA02, nafarelin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Nafarelin.]
[S01BA03, cortisone, The metabolism of Chloroquine can be increased when combined with Cortisone.]
[N07BC04, lofexidine, The metabolism of Lofexidine can be decreased when combined with Chloroquine.]
[S01AE04, lomefloxacin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Lomefloxacin.]
[M01AB09, lonazolac, Lonazolac may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[R06AX13, loratadine, The metabolism of Chloroquine can be decreased when combined with Loratadine.]
[M02AA31, loxoprofen, Loxoprofen may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DC08, loracarbef, Loracarbef may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C09AA03, lisinopril, Chloroquine may decrease the excretion rate of Lisinopril which could result in a higher serum level.]
[A02AD02, magaldrate, Magaldrate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A06AD01, magnesium carbonate, Magnesium carbonate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[B05XA10, magnesium phosphate, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Magnesium phosphate.]
[C08CA11, manidipine, The metabolism of Chloroquine can be decreased when combined with Manidipine.]
[A03AA04, mebeverine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Mebeverine.]
[C07AA14, mepindolol, The metabolism of Mepindolol can be decreased when combined with Chloroquine.]
[H02AB15, meprednisone, The metabolism of Chloroquine can be increased when combined with Meprednisone.]
[R06AD07, mequitazine, The metabolism of Mequitazine can be decreased when combined with Chloroquine.]
[J01DH02, meropenem, Chloroquine may decrease the excretion rate of Meropenem which could result in a higher serum level.]
[C01EB10, adenosine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Adenosine.]
[R06AE03, cyclizine, The risk or severity of QTc prolongation can be increased when Cyclizine is combined with Chloroquine.]
[C03DA04, eplerenone, Eplerenone may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AD03, metylperon, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Melperone.]
[C03AA07, cyclopenthiazide, Cyclopenthiazide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AF07, tenofovir disoproxil, Tenofovir disoproxil may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01AA01, cyclophosphamide, The metabolism of Cyclophosphamide can be decreased when combined with Chloroquine.]
[N06AX07, minaprine, The metabolism of Minaprine can be decreased when combined with Chloroquine.]
[S01XA18, cyclosporine, The serum concentration of Cyclosporine can be increased when it is combined with Chloroquine.]
[N06AG02, moclobemide, The metabolism of Moclobemide can be decreased when combined with Chloroquine.]
[N06BA07, modafinil, The metabolism of Chloroquine can be increased when combined with Modafinil.]
[R06AX02, cyproheptadine, The risk or severity of QTc prolongation can be increased when Cyproheptadine is combined with Chloroquine.]
[C09AA13, moexipril, The risk or severity of QTc prolongation can be increased when Moexipril is combined with Chloroquine.]
[C10AA07, rosuvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Rosuvastatin.]
[M02AA02, mofebutazone, Mofebutazone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[M01AX22, morniflumate, Morniflumate may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C03XA02, conivaptan, The metabolism of Chloroquine can be decreased when combined with Conivaptan.]
[L01BC01, cytarabine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Cytarabine.]
[G04BE09, vardenafil, The risk or severity of QTc prolongation can be increased when Vardenafil is combined with Chloroquine.]
[M01AH05, etoricoxib, Etoricoxib may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01AX04, dacarbazine, Chloroquine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.]
[G03XA01, danazol, The metabolism of Chloroquine can be decreased when combined with Danazol.]
[M03CA01, dantrolene, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Dantrolene.]
[J04BA02, dapsone, The risk or severity of methemoglobinemia can be increased when Dapsone is combined with Chloroquine.]
[L01DB02, daunorubicin, The metabolism of Chloroquine can be increased when combined with Daunorubicin.]
[C02CC04, debrisoquin, The metabolism of Debrisoquine can be decreased when combined with Chloroquine.]
[M01AX01, nabumetone, Nabumetone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N07BB05, nalmefene, Chloroquine may decrease the excretion rate of Nalmefene which could result in a higher serum level.]
[J01AA01, demeclocycline, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Demeclocycline.]
[C07AB12, nebivolol, The metabolism of Nebivolol can be decreased when combined with Chloroquine.]
[S01GX04, nedocromil, Chloroquine may decrease the excretion rate of Nedocromil which could result in a higher serum level.]
[N06AX06, nefazodone, The metabolism of Chloroquine can be decreased when combined with Nefazodone.]
[C01DX16, nicorandil, Chloroquine may decrease the excretion rate of Nicorandil which could result in a higher serum level.]
[L02BB02, nilutamide, The metabolism of Chloroquine can be decreased when combined with Nilutamide.]
[N03AG06, tiagabine, The therapeutic efficacy of Tiagabine can be decreased when used in combination with Chloroquine.]
[M03AC11, cisatracurium, The therapeutic efficacy of Cisatracurium can be increased when used in combination with Chloroquine.]
[B01AX05, fondaparinux, Fondaparinux may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N06AB10, escitalopram, The serum concentration of Chloroquine can be increased when it is combined with Escitalopram.]
[G04BD08, solifenacin, The metabolism of Solifenacin can be decreased when combined with Chloroquine.]
[A07EC03, olsalazine, Olsalazine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N06AA01, desipramine, The metabolism of Desipramine can be decreased when combined with Chloroquine.]
[C01AA07, deslanoside, The serum concentration of Deslanoside can be increased when it is combined with Chloroquine.]
[H01BA02, desmopressin, Desmopressin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01DH03, ertapenem, Ertapenem may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01XA03, oxaliplatin, The risk or severity of QTc prolongation can be increased when Oxaliplatin is combined with Chloroquine.]
[M01AE12, oxaprozin, Oxaprozin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N03AF02, oxcarbazepine, The metabolism of Chloroquine can be increased when combined with Oxcarbazepine.]
[S03BA01, dexamethasone, The metabolism of Chloroquine can be increased when combined with Dexamethasone.]
[G04BD04, oxybutynin, The metabolism of Chloroquine can be decreased when combined with Oxybutynin.]
[A08AA04, dexfenfluramine, The metabolism of Dexfenfluramine can be decreased when combined with Chloroquine.]
[L04AB04, adalimumab, The metabolism of Chloroquine can be increased when combined with Adalimumab.]
[L01EB01, gefitinib, The metabolism of Gefitinib can be decreased when combined with Chloroquine.]
[N06BA02, dextroamphetamine, The metabolism of Amphetamine can be decreased when combined with Chloroquine.]
[R05DA09, dextromethorphan, The metabolism of Dextromethorphan can be decreased when combined with Chloroquine.]
[N03AC01, paramethadione, The metabolism of Paramethadione can be decreased when combined with Chloroquine.]
[N06AB05, paroxetine, The metabolism of Paroxetine can be decreased when combined with Chloroquine.]
[B01AC04, clopidogrel, The metabolism of Chloroquine can be decreased when combined with Clopidogrel.]
[C01DA05, pentaerythritol tetranitrate, Chloroquine may decrease the excretion rate of Pentaerythritol tetranitrate which could result in a higher serum level.]
[P03AC04, permethrin, Chloroquine may decrease the excretion rate of Permethrin which could result in a higher serum level.]
[N05BA01, diazepam, The therapeutic efficacy of Diazepam can be decreased when used in combination with Chloroquine.]
[N03AX07, phenacemide, The therapeutic efficacy of Phenacemide can be decreased when used in combination with Chloroquine.]
[R02AA19, phenol, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Phenol.]
[N03AD02, phensuximide, The therapeutic efficacy of Phensuximide can be decreased when used in combination with Chloroquine.]
[S02DA04, dibucaine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Cinchocaine.]
[R05DA08, pholcodine, Chloroquine may decrease the excretion rate of Pholcodine which could result in a higher serum level.]
[S01EC02, dichlorphenamide, Diclofenamide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC03, diclofenac, The metabolism of Chloroquine can be decreased when combined with Diclofenac.]
[J05AD01, foscarnet, The risk or severity of QTc prolongation can be increased when Foscarnet is combined with Chloroquine.]
[A03AA07, dicyclomine, Chloroquine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.]
[J05AF02, didanosine, Chloroquine may decrease the excretion rate of Didanosine which could result in a higher serum level.]
[A03AX04, pinaverium, The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Chloroquine.]
[A10BG03, pioglitazone, The metabolism of Chloroquine can be decreased when combined with Pioglitazone.]
[L01EB02, erlotinib, The metabolism of Erlotinib can be decreased when combined with Chloroquine.]
[C03CA03, piretanide, Piretanide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[A16AB04, agalsidase beta, The therapeutic efficacy of Agalsidase beta can be decreased when used in combination with Chloroquine.]
[L02AA01, diethylstilbestrol, The metabolism of Chloroquine can be decreased when combined with Diethylstilbestrol.]
[C08CA03, isradipine, The metabolism of Chloroquine can be decreased when combined with Isradipine.]
[D07XC04, diflucortolone, The metabolism of Chloroquine can be increased when combined with Difluocortolone.]
[N02BA11, diflunisal, Diflunisal may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C01AA04, digitoxin, The serum concentration of Digitoxin can be increased when it is combined with Chloroquine.]
[C01AA05, digoxin, Chloroquine may decrease the excretion rate of Digoxin which could result in a higher serum level.]
[N02AA03, hydromorphone, Hydromorphone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L04AX04, lenalidomide, Lenalidomide may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J05AE08, atazanavir, The metabolism of Chloroquine can be decreased when combined with Atazanavir.]
[B01AC21, treprostinil, The metabolism of Chloroquine can be decreased when combined with Treprostinil.]
[H03BC01, potassium perchlorate, Chloroquine may decrease the excretion rate of Potassium perchlorate which could result in a higher serum level.]
[V03AB04, pralidoxime, Chloroquine may decrease the excretion rate of Pralidoxime which could result in a higher serum level.]
[D04AB07, pramoxine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Pramocaine.]
[C08DB01, diltiazem, The metabolism of Diltiazem can be decreased when combined with Chloroquine.]
[R06AA11, dimenhydrinate, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Dimenhydrinate.]
[V03AB09, dimercaprol, Chloroquine may decrease the excretion rate of Dimercaprol which could result in a higher serum level.]
[M02AX03, dimethyl sulfoxide, The metabolism of Chloroquine can be decreased when combined with Dimethyl sulfoxide.]
[N03AG05, progabide, The therapeutic efficacy of Progabide can be decreased when used in combination with Chloroquine.]
[N02BB04, propyphenazone, Propyphenazone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[M01AB14, proglumetacin, Proglumetacin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[S01HA04, proparacaine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Proparacaine.]
[R06AA02, diphenhydramine, The metabolism of Diphenhydramine can be decreased when combined with Chloroquine.]
[A03FA02, cisapride, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Cisapride.]
[S01XA23, sirolimus, The metabolism of Sirolimus can be decreased when combined with Chloroquine.]
[N05AL04, remoxipride, The metabolism of Remoxipride can be decreased when combined with Chloroquine.]
[S01AX06, resorcinol, Chloroquine may decrease the excretion rate of Resorcinol which could result in a higher serum level.]
[C01BA03, disopyramide, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Disopyramide.]
[P03AA04, disulfiram, The risk or severity of QTc prolongation can be increased when Disulfiram is combined with Chloroquine.]
[S02AA12, rifamycin SV, The metabolism of Chloroquine can be increased when combined with Rifamycin.]
[J04AB05, rifapentine, The metabolism of Chloroquine can be increased when combined with Rifapentine.]
[N07XX02, riluzole, The therapeutic efficacy of Riluzole can be decreased when used in combination with Chloroquine.]
[N05AX08, risperidone, The metabolism of Risperidone can be decreased when combined with Chloroquine.]
[R06AE09, levocetirizine, The risk or severity of QTc prolongation can be increased when Levocetirizine is combined with Chloroquine.]
[N01BB09, ropivacaine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Ropivacaine.]
[J01MB01, rosoxacin, The risk or severity of QTc prolongation can be increased when Rosoxacin is combined with Chloroquine.]
[L01EX01, sunitinib, The metabolism of Sunitinib can be decreased when combined with Chloroquine.]
[A04AD12, aprepitant, The metabolism of Chloroquine can be decreased when combined with Aprepitant.]
[C03XA01, tolvaptan, Tolvaptan may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[L01XG01, bortezomib, The metabolism of Bortezomib can be decreased when combined with Chloroquine.]
[G04BE08, tadalafil, Chloroquine may decrease the excretion rate of Tadalafil which could result in a higher serum level.]
[S01BC05, ketorolac, The metabolism of Chloroquine can be decreased when combined with Ketorolac.]
[C02KX02, ambrisentan, The metabolism of Ambrisentan can be decreased when combined with Chloroquine.]
[C01EB18, ranolazine, The serum concentration of Chloroquine can be increased when it is combined with Ranolazine.]
[N02BA06, salsalate, Salsalate may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[R03AC12, salmeterol, The metabolism of Chloroquine can be decreased when combined with Salmeterol.]
[H05BA01, salmon calcitonin, Salmon calcitonin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C01CA07, dobutamine, Chloroquine may decrease the excretion rate of Dobutamine which could result in a higher serum level.]
[A03FA03, domperidone, The metabolism of Domperidone can be decreased when combined with Chloroquine.]
[C01CA04, dopamine, Chloroquine may decrease the excretion rate of Dopamine which could result in a higher serum level.]
[N06AA16, dothiepin, The metabolism of Dosulepin can be decreased when combined with Chloroquine.]
[N06AA12, doxepin, The metabolism of Doxepin can be decreased when combined with Chloroquine.]
[L01DB01, doxorubicin, The metabolism of Chloroquine can be decreased when combined with Doxorubicin.]
[J01AA02, doxycycline, The risk or severity of neuromuscular blockade can be increased when Doxycycline is combined with Chloroquine.]
[R06AA09, doxylamine, The risk or severity of QTc prolongation can be increased when Doxylamine is combined with Chloroquine.]
[N06AB06, sertraline, The metabolism of Sertraline can be decreased when combined with Chloroquine.]
[N01AB08, sevoflurane, The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Chloroquine.]
[N05AD08, droperidol, The risk or severity of QTc prolongation can be increased when Droperidol is combined with Chloroquine.]
[A08AA10, sibutramine, Chloroquine may decrease the excretion rate of Sibutramine which could result in a higher serum level.]
[C10AA01, simvastatin, The metabolism of Simvastatin can be decreased when combined with Chloroquine.]
[B05XA02, sodium bicarbonate, Sodium bicarbonate can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CA02, sodium sulfate, Chloroquine may decrease the excretion rate of Sodium sulfate which could result in a higher serum level.]
[R03DA01, dyphylline, Chloroquine may decrease the excretion rate of Dyphylline which could result in a higher serum level.]
[N05AL02, sultopride, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Sultopride.]
[N02CC01, sumatriptan, Chloroquine may decrease the excretion rate of Sumatriptan which could result in a higher serum level.]
[V04CX07, edrophonium, Chloroquine may decrease the excretion rate of Edrophonium which could result in a higher serum level.]
[C07AB13, talinolol, The metabolism of Talinolol can be decreased when combined with Chloroquine.]
[J01MA05, temafloxacin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Temafloxacin.]
[L01AX03, temozolomide, Chloroquine may decrease the excretion rate of Temozolomide which could result in a higher serum level.]
[M01AC02, tenoxicam, Tenoxicam may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[D01BA02, terbinafine, The metabolism of Chloroquine can be decreased when combined with Terbinafine.]
[G04BD05, terodiline, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Terodiline.]
[C07AA16, tertatolol, The metabolism of Tertatolol can be decreased when combined with Chloroquine.]
[P01AX02, emetine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Emetine.]
[N06AX14, tianeptine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Tianeptine.]
[C09AA02, enalapril, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Enalapril is combined with Chloroquine.]
[M01AG02, tolfenamic acid, Tolfenamic acid may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N06AG03, toloxatone, Chloroquine may decrease the excretion rate of Toloxatone which could result in a higher serum level.]
[N06BA09, atomoxetine, The metabolism of Atomoxetine can be decreased when combined with Chloroquine.]
[N03AX11, topiramate, The therapeutic efficacy of Topiramate can be decreased when used in combination with Chloroquine.]
[L02BA02, toremifene, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Toremifene.]
[C03CA04, torsemide, Torasemide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[J01AA12, tigecycline, The risk or severity of neuromuscular blockade can be increased when Tigecycline is combined with Chloroquine.]
[L02AE04, triptorelin, The risk or severity of QTc prolongation can be increased when Triptorelin is combined with Chloroquine.]
[J01MA04, enoxacin, The risk or severity of QTc prolongation can be increased when Enoxacin is combined with Chloroquine.]
[L01CA04, vinorelbine, The metabolism of Chloroquine can be decreased when combined with Vinorelbine.]
[S01GX10, epinastine, The metabolism of Epinastine can be decreased when combined with Chloroquine.]
[N06AX16, venlafaxine, The metabolism of Chloroquine can be decreased when combined with Venlafaxine.]
[C08CA12, mepirodipine, The metabolism of Chloroquine can be decreased when combined with Barnidipine.]
[N05CF02, zolpidem, The metabolism of Zolpidem can be decreased when combined with Chloroquine.]
[M01AB04, zomepirac, Zomepirac may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N03AX15, zonisamide, Zonisamide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF01, zopiclone, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Zopiclone.]
[L01XA02, carboplatin, Carboplatin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C02AC02, guanfacine, Chloroquine may decrease the excretion rate of Guanfacine which could result in a higher serum level.]
[B01AC11, iloprost, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Iloprost.]
[C01BG01, moricizine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Moricizine.]
[N02CA02, ergotamine, The metabolism of Chloroquine can be decreased when combined with Ergotamine.]
[L03AX05, pidotimod, Chloroquine may decrease the excretion rate of Pidotimod which could result in a higher serum level.]
[S01AA17, erythromycin, The risk or severity of QTc prolongation can be increased when Erythromycin is combined with Chloroquine.]
[N05CD04, estazolam, The therapeutic efficacy of Estazolam can be decreased when used in combination with Chloroquine.]
[A02BC02, pantoprazole, Pantoprazole may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[H05BX01, cinacalcet, The metabolism of Chloroquine can be decreased when combined with Cinacalcet.]
[G03CA03, estradiol, The metabolism of Estradiol can be decreased when combined with Chloroquine.]
[G03CA57, estrogens, conjugated (USP), Conjugated estrogens may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J04AK02, ethambutol, Ethambutol may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[R03BA09, fluticasone furoate, The metabolism of Chloroquine can be decreased when combined with Fluticasone furoate.]
[R03BA05, fluticasone, The metabolism of Chloroquine can be decreased when combined with Fluticasone.]
[C10AA04, fluvastatin, The metabolism of Fluvastatin can be decreased when combined with Chloroquine.]
[V08CA03, gadodiamide, Gadodiamide may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L02AA03, ethinyl estradiol, The metabolism of Chloroquine can be decreased when combined with Ethinylestradiol.]
[C01BD05, ibutilide, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Ibutilide.]
[N03AD01, ethosuximide, The therapeutic efficacy of Ethosuximide can be decreased when used in combination with Chloroquine.]
[N03AB01, ethotoin, The therapeutic efficacy of Ethotoin can be decreased when used in combination with Chloroquine.]
[N01BX01, ethyl chloride, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Ethyl chloride.]
[M01AC06, meloxicam, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Meloxicam.]
[S01XA06, ethylmorphine, The metabolism of Ethylmorphine can be decreased when combined with Chloroquine.]
[N01BB07, etidocaine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Etidocaine.]
[N01AX07, etomidate, Etomidate may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01CB01, etoposide, The metabolism of Etoposide can be decreased when combined with Chloroquine.]
[N05AE03, sertindole, The metabolism of Sertindole can be decreased when combined with Chloroquine.]
[C01BA05, ajmaline, The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Chloroquine.]
[L04AD02, tacrolimus, The metabolism of Tacrolimus can be decreased when combined with Chloroquine.]
[A02BA04, nizatidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Nizatidine is combined with Chloroquine.]
[J01MA08, fleroxacin, The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Chloroquine.]
[R06AX11, astemizole, The metabolism of Astemizole can be decreased when combined with Chloroquine.]
[R06AX12, terfenadine, The metabolism of Chloroquine can be decreased when combined with Terfenadine.]
[P01AX07, trimetrexate, Chloroquine may decrease the excretion rate of Trimetrexate which could result in a higher serum level.]
[N06AX12, bupropion, The risk or severity of seizure can be increased when Bupropion is combined with Chloroquine.]
[N06AB08, fluvoxamine, The metabolism of Chloroquine can be decreased when combined with Fluvoxamine.]
[C01BC08, encainide, The metabolism of Encainide can be decreased when combined with Chloroquine.]
[L02AE02, leuprolide, The risk or severity of QTc prolongation can be increased when Leuprolide is combined with Chloroquine.]
[C10AA03, pravastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Pravastatin is combined with Chloroquine.]
[M01CB01, gold sodium thiomalate, Chloroquine may decrease the excretion rate of Sodium aurothiomalate which could result in a higher serum level.]
[B05AA05, dextran, Chloroquine may decrease the excretion rate of Dextran which could result in a higher serum level.]
[V03AF02, dexrazoxane, Dexrazoxane may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[A02BA03, famotidine, The risk or severity of QTc prolongation can be increased when Famotidine is combined with Chloroquine.]
[A16AA01, levocarnitine, Levocarnitine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C08CA02, felodipine, The metabolism of Chloroquine can be decreased when combined with Felodipine.]
[C08EA01, fendiline, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Fendiline.]
[N03AX26, fenfluramine, The metabolism of Fenfluramine can be decreased when combined with Chloroquine.]
[M01AE04, fenoprofen, Fenoprofen may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N02AB03, fentanyl, Chloroquine may decrease the excretion rate of Fentanyl which could result in a higher serum level.]
[R03CC02, albuterol, The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Chloroquine.]
[L01BB06, clofarabine, Chloroquine may decrease the excretion rate of Clofarabine which could result in a higher serum level.]
[L04AA40, cladribine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cladribine is combined with Chloroquine.]
[N07AX03, cevimeline, The metabolism of Cevimeline can be decreased when combined with Chloroquine.]
[G04BD02, flavoxate, Chloroquine may decrease the excretion rate of Flavoxate which could result in a higher serum level.]
[C01BC04, flecainide, The metabolism of Flecainide can be decreased when combined with Chloroquine.]
[N02BG04, floctafenine, Floctafenine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J02AC01, fluconazole, The metabolism of Chloroquine can be decreased when combined with Fluconazole.]
[J02AX01, flucytosine, Chloroquine may decrease the excretion rate of Flucytosine which could result in a higher serum level.]
[V03AB25, flumazenil, Chloroquine may decrease the excretion rate of Flumazenil which could result in a higher serum level.]
[N07CA03, flunarizine, The metabolism of Flunarizine can be decreased when combined with Chloroquine.]
[D07AC08, fluocinonide, The metabolism of Chloroquine can be increased when combined with Fluocinonide.]
[H02AB03, fluocortolone, The metabolism of Chloroquine can be increased when combined with Fluocortolone.]
[V03AZ01, ethanol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Ethanol.]
[L01BC09, floxuridine, Floxuridine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01BC02, fluorouracil, The metabolism of Fluorouracil can be decreased when combined with Chloroquine.]
[N06AB03, fluoxetine, The serum concentration of Chloroquine can be increased when it is combined with Fluoxetine.]
[N05AF01, flupenthixol, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Flupentixol.]
[N05AB02, fluphenazine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Fluphenazine.]
[N05CD01, flurazepam, Chloroquine may decrease the excretion rate of Flurazepam which could result in a higher serum level.]
[S01BC04, flurbiprofen, Flurbiprofen may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N05AG01, fluspirilene, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Fluspirilene.]
[L02BB01, flutamide, The risk or severity of methemoglobinemia can be increased when Flutamide is combined with Chloroquine.]
[V04CX02, folic acid, Folic acid may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[S02AA17, fosfomycin, Chloroquine may decrease the excretion rate of Fosfomycin which could result in a higher serum level.]
[S01AA07, framycetin, The risk or severity of neuromuscular blockade can be increased when Framycetin is combined with Chloroquine.]
[L01BC03, tegafur, The metabolism of Tegafur can be decreased when combined with Chloroquine.]
[M03AA01, alcuronium, The therapeutic efficacy of Alcuronium can be increased when used in combination with Chloroquine.]
[J05AE10, darunavir, The metabolism of Chloroquine can be decreased when combined with Darunavir.]
[C03CA01, furosemide, Furosemide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05CF04, eszopiclone, The metabolism of Chloroquine can be decreased when combined with Eszopiclone.]
[N05AL05, amisulpride, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Amisulpride.]
[N06DA04, galantamine, The metabolism of Galantamine can be decreased when combined with Chloroquine.]
[M03AC02, gallamine, The therapeutic efficacy of Gallamine can be increased when used in combination with Chloroquine.]
[C08DA02, gallopamil, The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Chloroquine.]
[S01AD09, ganciclovir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Ganciclovir.]
[N03AA04, barbexaclone, The therapeutic efficacy of Barbexaclone can be decreased when used in combination with Chloroquine.]
[C10AB04, gemfibrozil, The metabolism of Chloroquine can be decreased when combined with Gemfibrozil.]
[J01XA03, telavancin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Telavancin.]
[L02BX02, degarelix, The risk or severity of QTc prolongation can be increased when Degarelix is combined with Chloroquine.]
[L01EA02, dasatinib, The metabolism of Dasatinib can be decreased when combined with Chloroquine.]
[N03AD03, methsuximide, The therapeutic efficacy of Methsuximide can be decreased when used in combination with Chloroquine.]
[N01AH02, alfentanil, The metabolism of Alfentanil can be decreased when combined with Chloroquine.]
[L01EH01, lapatinib, The metabolism of Lapatinib can be decreased when combined with Chloroquine.]
[A10BB01, glyburide, The metabolism of Glyburide can be decreased when combined with Chloroquine.]
[A10BB07, glipizide, Chloroquine may decrease the excretion rate of Glipizide which could result in a higher serum level.]
[N05CM18, dexmedetomidine, The metabolism of Chloroquine can be decreased when combined with Dexmedetomidine.]
[C05AE01, nitroglycerin, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Nitroglycerin.]
[C01BD04, dofetilide, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Dofetilide.]
[C02CA04, doxazosin, The metabolism of Doxazosin can be decreased when combined with Chloroquine.]
[L01EX02, sorafenib, The metabolism of Sorafenib can be decreased when combined with Chloroquine.]
[C07AB09, esmolol, The metabolism of Esmolol can be decreased when combined with Chloroquine.]
[M01CB04, aurothioglucose, Chloroquine may decrease the excretion rate of Aurothioglucose which could result in a higher serum level.]
[S01LA03, pegaptanib, Chloroquine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.]
[C09AA09, fosinopril, Fosinopril may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[S01EX01, guanethidine, Chloroquine may decrease the excretion rate of Guanethidine which could result in a higher serum level.]
[L02AE03, goserelin, The risk or severity of QTc prolongation can be increased when Goserelin is combined with Chloroquine.]
[P01BX01, halofantrine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Halofantrine.]
[N05AD01, haloperidol, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Haloperidol.]
[L02AE05, histrelin, The risk or severity of QTc prolongation can be increased when Histrelin is combined with Chloroquine.]
[N05AH04, quetiapine, The metabolism of Quetiapine can be decreased when combined with Chloroquine.]
[N06BX13, idebenone, Chloroquine may decrease the excretion rate of Idebenone which could result in a higher serum level.]
[L01CE02, irinotecan, The metabolism of Irinotecan can be decreased when combined with Chloroquine.]
[M04AA01, allopurinol, Allopurinol may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C09CA01, losartan, The metabolism of Chloroquine can be decreased when combined with Losartan.]
[B05CB03, magnesium citrate, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Magnesium citrate.]
[A12CC03, magnesium gluconate, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Magnesium gluconate.]
[G03DC01, allylestrenol, Chloroquine may decrease the excretion rate of Allylestrenol which could result in a higher serum level.]
[A07EC02, mesalamine, Mesalazine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C01CE02, milrinone, Milrinone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N05CA16, hexobarbital, The therapeutic efficacy of Hexobarbital can be decreased when used in combination with Chloroquine.]
[J05AG01, nevirapine, The metabolism of Nevirapine can be decreased when combined with Chloroquine.]
[C08CA10, nilvadipine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Nilvadipine.]
[M02AA26, nimesulide, Nimesulide may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[R06AE06, oxatomide, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Oxatomide.]
[C09AA04, perindopril, Chloroquine may decrease the excretion rate of Perindopril which could result in a higher serum level.]
[C02DB02, hydralazine, Chloroquine may decrease the excretion rate of Hydralazine which could result in a higher serum level.]
[C03AA03, hydrochlorothiazide, Hydrochlorothiazide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[R05DA03, hydrocodone, The metabolism of Hydrocodone can be decreased when combined with Chloroquine.]
[S02BA01, hydrocortisone, The metabolism of Chloroquine can be increased when combined with Hydrocortisone.]
[C03AA02, hydroflumethiazide, Hydroflumethiazide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[B05XA17, potassium acetate, Chloroquine may decrease the excretion rate of Potassium acetate which could result in a higher serum level.]
[A12BA02, potassium citrate, Potassium citrate may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB33, hydroxocobalamin, Hydroxocobalamin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[G04BD06, propiverine, Chloroquine may decrease the excretion rate of Propiverine which could result in a higher serum level.]
[P01BA02, hydroxychloroquine, The metabolism of Hydroxychloroquine can be decreased when combined with Chloroquine.]
[B05AA07, hetastarch, Chloroquine may decrease the excretion rate of Hydroxyethyl Starch which could result in a higher serum level.]
[L01XX05, hydroxyurea, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Hydroxyurea.]
[N05BB01, hydroxyzine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Hydroxyzine.]
[J04AB04, rifabutin, The metabolism of Chloroquine can be increased when combined with Rifabutin.]
[M05BA07, risedronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Risedronic acid.]
[R02AX02, ibuprofen, The metabolism of Ibuprofen can be decreased when combined with Chloroquine.]
[B05XA08, sodium acetate, Chloroquine may decrease the excretion rate of Sodium acetate which could result in a higher serum level.]
[L01DB06, idarubicin, The metabolism of Idarubicin can be decreased when combined with Chloroquine.]
[L01AA06, ifosfamide, The metabolism of Ifosfamide can be decreased when combined with Chloroquine.]
[N06AA02, imipramine, The metabolism of Chloroquine can be decreased when combined with Imipramine.]
[L01CD01, paclitaxel, The metabolism of Paclitaxel can be decreased when combined with Chloroquine.]
[H01BA04, terlipressin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Terlipressin.]
[R01AD07, tixocortol, Chloroquine may decrease the excretion rate of Tixocortol which could result in a higher serum level.]
[M03BX02, tizanidine, The therapeutic efficacy of Tizanidine can be decreased when used in combination with Chloroquine.]
[L01CE01, topotecan, Chloroquine may decrease the excretion rate of Topotecan which could result in a higher serum level.]
[C03BA11, indapamide, Indapamide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[S01BC01, indomethacin, Indomethacin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[A11HA07, inositol, Chloroquine may decrease the excretion rate of Inositol which could result in a higher serum level.]
[N06AX17, milnacipran, The metabolism of Chloroquine can be decreased when combined with Milnacipran.]
[R01AA02, cyclopentamine, The risk or severity of adverse effects can be increased when Chloroquine is combined with Cyclopentamine.]
[S01XA28, varenicline, Chloroquine may decrease the excretion rate of Varenicline which could result in a higher serum level.]
[N01BB08, articaine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Articaine.]
[A10BH01, sitagliptin, The metabolism of Sitagliptin can be decreased when combined with Chloroquine.]
[N05BA12, alprazolam, Alprazolam may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N05CH02, ramelteon, Chloroquine may decrease the excretion rate of Ramelteon which could result in a higher serum level.]
[R06AE01, buclizine, The risk or severity of QTc prolongation can be increased when Buclizine is combined with Chloroquine.]
[C10AA06, cerivastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Cerivastatin is combined with Chloroquine.]
[L01XX35, anagrelide, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Anagrelide.]
[C07AA01, alprenolol, The metabolism of Alprenolol can be decreased when combined with Chloroquine.]
[C03BA02, quinethazone, Quinethazone may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[V03AB01, ipecac, The metabolism of Ipecac can be decreased when combined with Chloroquine.]
[J05AF04, stavudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Stavudine.]
[N06AF05, iproniazid, The metabolism of Chloroquine can be decreased when combined with Iproniazid.]
[N05AA07, chlorproethazine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Chlorproethazine.]
[N01AB06, isoflurane, The risk or severity of QTc prolongation can be increased when Isoflurane is combined with Chloroquine.]
[N04BX02, entacapone, The metabolism of Chloroquine can be decreased when combined with Entacapone.]
[J04AC01, isoniazid, The metabolism of Chloroquine can be decreased when combined with Isoniazid.]
[J05AX05, inosine pranobex, Chloroquine may decrease the excretion rate of Inosine pranobex which could result in a higher serum level.]
[C01DA14, isosorbide mononitrate, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Isosorbide mononitrate.]
[C05AE02, isosorbide dinitrate, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Isosorbide dinitrate.]
[D10BA01, isotretinoin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Isotretinoin.]
[P02CF01, ivermectin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Ivermectin is combined with Chloroquine.]
[N06AX18, reboxetine, The metabolism of Chloroquine can be decreased when combined with Reboxetine.]
[S01AA24, kanamycin, Chloroquine may decrease the excretion rate of Kanamycin which could result in a higher serum level.]
[A07BC02, kaolin, Kaolin can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[H01AC01, somatropin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Somatotropin is combined with Chloroquine.]
[A02AB01, aluminum hydroxide, Aluminum hydroxide can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[L04AC07, tocilizumab, The metabolism of Chloroquine can be increased when combined with Tocilizumab.]
[N01AX03, ketamine, The metabolism of Ketamine can be decreased when combined with Chloroquine.]
[B01AC22, prasugrel, Chloroquine may decrease the excretion rate of Prasugrel which could result in a higher serum level.]
[H02CA04, levoketoconazole, The metabolism of Chloroquine can be decreased when combined with Levoketoconazole.]
[J02AB02, ketoconazole, The metabolism of Chloroquine can be decreased when combined with Ketoconazole.]
[N05AH03, olanzapine, The metabolism of Olanzapine can be decreased when combined with Chloroquine.]
[M02AA10, ketoprofen, Ketoprofen may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[V03AC03, deferasirox, The metabolism of Chloroquine can be decreased when combined with Deferasirox.]
[L04AA24, abatacept, The metabolism of Chloroquine can be increased when combined with Abatacept.]
[R06AX25, mizolastine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Mizolastine.]
[N04BC09, rotigotine, The metabolism of Rotigotine can be decreased when combined with Chloroquine.]
[J01MB02, nalidixic acid, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Nalidixic acid.]
[M01AE11, tiaprofenic acid, Tiaprofenic acid may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C07AG01, labetalol, The metabolism of Labetalol can be decreased when combined with Chloroquine.]
[N04BB01, amantadine, The risk or severity of QTc prolongation can be increased when Amantadine is combined with Chloroquine.]
[A06AX03, lubiprostone, Chloroquine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.]
[N03AX18, lacosamide, The therapeutic efficacy of Lacosamide can be decreased when used in combination with Chloroquine.]
[C03CC01, ethacrynic acid, Etacrynic acid may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[G03AD01, levonorgestrel, The metabolism of Chloroquine can be decreased when combined with Levonorgestrel.]
[S02DA01, lidocaine, The metabolism of Lidocaine can be decreased when combined with Chloroquine.]
[C08EX01, lidoflazine, The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Chloroquine.]
[J01FF02, lincomycin, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Lincomycin.]
[S01AA21, amikacin, Chloroquine may decrease the excretion rate of Amikacin which could result in a higher serum level.]
[N06BA13, armodafinil, The metabolism of Chloroquine can be increased when combined with Armodafinil.]
[C03DB01, amiloride, Amiloride may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N02CA07, lisuride, The metabolism of Lisuride can be decreased when combined with Chloroquine.]
[A07DA03, loperamide, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Loperamide.]
[N05BA06, lorazepam, The therapeutic efficacy of Lorazepam can be decreased when used in combination with Chloroquine.]
[C10AA02, lovastatin, The metabolism of Chloroquine can be decreased when combined with Lovastatin.]
[J01AA04, lymecycline, The risk or severity of neuromuscular blockade can be increased when Lymecycline is combined with Chloroquine.]
[L01EG01, temsirolimus, The metabolism of Temsirolimus can be decreased when combined with Chloroquine.]
[B05XA11, magnesium chloride, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Magnesium chloride.]
[G04BX01, magnesium hydroxide, Magnesium hydroxide can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[A12CC10, magnesium oxide, Magnesium oxide can cause a decrease in the absorption of Chloroquine resulting in a reduced serum concentration and potentially a decrease in efficacy.]
[V04CC02, magnesium sulfate, The therapeutic efficacy of Magnesium sulfate can be decreased when used in combination with Chloroquine.]
[L01BA05, pralatrexate, Chloroquine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.]
[L01EA03, nilotinib, The metabolism of Chloroquine can be decreased when combined with Nilotinib.]
[V04CX04, mannitol, Mannitol may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06AA21, maprotiline, The metabolism of Maprotiline can be decreased when combined with Chloroquine.]
[C02BB01, mecamylamine, The risk or severity of adverse effects can be increased when Chloroquine is combined with Mecamylamine.]
[R06AE05, meclizine, The metabolism of Meclizine can be decreased when combined with Chloroquine.]
[M02AA18, meclofenamic acid, Meclofenamic acid may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N05BA03, medazepam, The therapeutic efficacy of Medazepam can be decreased when used in combination with Chloroquine.]
[C01AA08, medigoxin, The serum concentration of Metildigoxin can be increased when it is combined with Chloroquine.]
[P01BC02, mefloquine, The risk or severity of adverse effects can be increased when Chloroquine is combined with Mefloquine.]
[C03BA05, mefruside, Mefruside may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N06DX01, memantine, Chloroquine may decrease the excretion rate of Memantine which could result in a higher serum level.]
[N02AB02, meperidine, Meperidine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N03AB04, mephenytoin, The metabolism of Mephenytoin can be decreased when combined with Chloroquine.]
[N03AA01, mephobarbital, The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Chloroquine.]
[N01BB03, mepivacaine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Mepivacaine.]
[G04BX16, tiopronin, Chloroquine may decrease the excretion rate of Tiopronin which could result in a higher serum level.]
[C03BC01, mersalyl, Mersalyl may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[N05AC03, mesoridazine, The metabolism of Mesoridazine can be decreased when combined with Chloroquine.]
[N05AX13, paliperidone, The metabolism of Paliperidone can be decreased when combined with Chloroquine.]
[A10BA02, metformin, Metformin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[A04AA04, dolasetron, The metabolism of Dolasetron can be decreased when combined with Chloroquine.]
[J01AA05, methacycline, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Metacycline.]
[N07BC02, methadone, The metabolism of Methadone can be decreased when combined with Chloroquine.]
[N06BA03, methamphetamine, The metabolism of Metamfetamine can be decreased when combined with Chloroquine.]
[J05AF05, lamivudine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Lamivudine.]
[N03AA30, metharbital, The therapeutic efficacy of Metharbital can be decreased when used in combination with Chloroquine.]
[S01EC05, methazolamide, Methazolamide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[H03BB02, methimazole, The metabolism of Chloroquine can be decreased when combined with Methimazole.]
[L01BA04, pemetrexed, Chloroquine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.]
[N05CA15, methohexital, The therapeutic efficacy of Methohexital can be decreased when used in combination with Chloroquine.]
[A11HA02, pyridoxine, Pyridoxine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L04AX03, methotrexate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Methotrexate is combined with Chloroquine.]
[N05AA02, methotrimeprazine, The metabolism of Methotrimeprazine can be decreased when combined with Chloroquine.]
[D05BA02, methoxsalen, Methoxsalen may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N02BG09, methoxyflurane, The metabolism of Methoxyflurane can be decreased when combined with Chloroquine.]
[C03AA08, methyclothiazide, Methyclothiazide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[C02AB01, methyldopa, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Methyldopa.]
[V04CG05, methylene blue, The metabolism of Methylene blue can be decreased when combined with Chloroquine.]
[N03AF03, rufinamide, The therapeutic efficacy of Rufinamide can be decreased when used in combination with Chloroquine.]
[G03EK01, methyltestosterone, Chloroquine may decrease the excretion rate of Methyltestosterone which could result in a higher serum level.]
[A03FA01, metoclopramide, The metabolism of Metoclopramide can be decreased when combined with Chloroquine.]
[C03BA08, metolazone, Metolazone may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[C07AB02, metoprolol, The metabolism of Chloroquine can be decreased when combined with Metoprolol.]
[P01AB01, metronidazole, The metabolism of Chloroquine can be decreased when combined with Metronidazole.]
[V04CD01, metyrapone, Chloroquine may decrease the excretion rate of Metyrapone which could result in a higher serum level.]
[C01BB02, mexiletine, The metabolism of Mexiletine can be decreased when combined with Chloroquine.]
[N06AX03, mianserin, The metabolism of Mianserin can be decreased when combined with Chloroquine.]
[S02AA13, miconazole, The metabolism of Chloroquine can be decreased when combined with Miconazole.]
[N02BB03, aminopyrine, The metabolism of Aminophenazone can be decreased when combined with Chloroquine.]
[N05CD08, midazolam, Chloroquine may decrease the excretion rate of Midazolam which could result in a higher serum level.]
[G03XB01, mifepristone, The serum concentration of Chloroquine can be increased when it is combined with Mifepristone.]
[J05AH01, zanamivir, Zanamivir may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01AA08, minocycline, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Minocycline.]
[L01XX23, mitotane, The metabolism of Chloroquine can be increased when combined with Mitotane.]
[N06BA12, lisdexamfetamine, The metabolism of Lisdexamfetamine can be decreased when combined with Chloroquine.]
[L03AC01, aldesleukin, Aldesleukin may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C01BD01, amiodarone, The metabolism of Chloroquine can be decreased when combined with Amiodarone.]
[N06AA09, amitriptyline, The metabolism of Amitriptyline can be decreased when combined with Chloroquine.]
[N02AA01, morphine, The metabolism of Chloroquine can be decreased when combined with Morphine.]
[A04AA05, palonosetron, The metabolism of Palonosetron can be decreased when combined with Chloroquine.]
[J01DD06, moxalactam, Latamoxef may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L04AB05, certolizumab pegol, The metabolism of Chloroquine can be increased when combined with Certolizumab pegol.]
[B02BX05, eltrombopag, The metabolism of Chloroquine can be decreased when combined with Eltrombopag.]
[G04BA01, ammonium chloride, Chloroquine may decrease the excretion rate of Ammonium chloride which could result in a higher serum level.]
[L01EX03, pazopanib, The metabolism of Pazopanib can be decreased when combined with Chloroquine.]
[L04AA06, mycophenolic acid, Chloroquine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.]
[M03AC03, vecuronium, The therapeutic efficacy of Vecuronium can be increased when used in combination with Chloroquine.]
[N05CA02, amobarbital, The therapeutic efficacy of Amobarbital can be decreased when used in combination with Chloroquine.]
[J05AJ01, raltegravir, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Raltegravir.]
[P01BA06, amodiaquine, The metabolism of Amodiaquine can be decreased when combined with Chloroquine.]
[G03XC01, raloxifene, The metabolism of Chloroquine can be decreased when combined with Raloxifene.]
[N06AA17, amoxapine, The metabolism of Amoxapine can be decreased when combined with Chloroquine.]
[N03AB05, fosphenytoin, The metabolism of Fosphenytoin can be decreased when combined with Chloroquine.]
[C07AA12, nadolol, The metabolism of Nadolol can be decreased when combined with Chloroquine.]
[J01CA04, amoxicillin, Chloroquine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.]
[V03AB15, naloxone, The metabolism of Chloroquine can be decreased when combined with Naloxone.]
[N07BB04, naltrexone, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Naltrexone.]
[L04AC03, anakinra, The metabolism of Chloroquine can be increased when combined with Anakinra.]
[N06BA01, amphetamine, The metabolism of Amphetamine can be decreased when combined with Chloroquine.]
[M02AA12, naproxen, The metabolism of Naproxen can be decreased when combined with Chloroquine.]
[A10BG01, troglitazone, The metabolism of Chloroquine can be decreased when combined with Troglitazone.]
[N06AX21, duloxetine, The metabolism of Chloroquine can be decreased when combined with Duloxetine.]
[N04BX01, tolcapone, Tolcapone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[L01CD02, docetaxel, The metabolism of Docetaxel can be decreased when combined with Chloroquine.]
[L02BG04, letrozole, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Letrozole.]
[S03AA01, neomycin, Chloroquine may decrease the excretion rate of Neomycin which could result in a higher serum level.]
[A10BX02, repaglinide, The metabolism of Repaglinide can be decreased when combined with Chloroquine.]
[C01CX08, levosimendan, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Levosimendan.]
[B01AC17, tirofiban, Chloroquine may decrease the excretion rate of Tirofiban which could result in a higher serum level.]
[N05AX14, iloperidone, The metabolism of Iloperidone can be decreased when combined with Chloroquine.]
[J02AA01, amphotericin B, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Amphotericin B.]
[S01AA19, ampicillin, The bioavailability of Ampicillin can be decreased when combined with Chloroquine.]
[L03AX16, plerixafor, Chloroquine may decrease the excretion rate of Plerixafor which could result in a higher serum level.]
[S01AA23, netilmicin, Chloroquine may decrease the excretion rate of Netilmicin which could result in a higher serum level.]
[N06AX23, desvenlafaxine, The metabolism of Chloroquine can be decreased when combined with Desvenlafaxine.]
[J05AB11, valacyclovir, Valaciclovir may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C01CE01, inamrinone, Chloroquine may decrease the excretion rate of Amrinone which could result in a higher serum level.]
[C10AD02, niacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Niacin.]
[C08CA04, nicardipine, The metabolism of Chloroquine can be decreased when combined with Nicardipine.]
[C04AE02, nicergoline, The metabolism of Nicergoline can be decreased when combined with Chloroquine.]
[N07BA01, nicotine, The risk or severity of adverse effects can be increased when Chloroquine is combined with Nicotine.]
[C08CA05, nifedipine, The metabolism of Nifedipine can be decreased when combined with Chloroquine.]
[M02AA17, niflumic acid, Niflumic acid may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[V03AB22, amyl nitrite, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Amyl Nitrite.]
[C08CA06, nimodipine, The risk or severity of QTc prolongation can be increased when Nimodipine is combined with Chloroquine.]
[C08CA07, nisoldipine, Nisoldipine may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N05CD02, nitrazepam, The therapeutic efficacy of Nitrazepam can be decreased when used in combination with Chloroquine.]
[C08CA08, nitrendipine, The risk or severity of QTc prolongation can be increased when Nitrendipine is combined with Chloroquine.]
[R07AX01, nitric oxide, The risk or severity of methemoglobinemia can be increased when Nitric Oxide is combined with Chloroquine.]
[J01XE01, nitrofurantoin, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Nitrofurantoin.]
[N05CF03, zaleplon, The therapeutic efficacy of Zaleplon can be decreased when used in combination with Chloroquine.]
[N04BC05, pramipexole, Pramipexole may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C02DD01, nitroprusside, The risk or severity of methemoglobinemia can be increased when Nitroprusside is combined with Chloroquine.]
[N01AX13, nitrous oxide, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Nitrous oxide.]
[G03DC02, norethindrone, The metabolism of Norethisterone can be decreased when combined with Chloroquine.]
[S01AE02, norfloxacin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Norfloxacin.]
[N06AA10, nortriptyline, The metabolism of Nortriptyline can be decreased when combined with Chloroquine.]
[H01CB02, octreotide, The risk or severity of QTc prolongation can be increased when Octreotide is combined with Chloroquine.]
[S02AA16, ofloxacin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Ofloxacin.]
[L04AC04, rilonacept, The metabolism of Chloroquine can be increased when combined with Rilonacept.]
[A02BC01, omeprazole, The metabolism of Chloroquine can be decreased when combined with Omeprazole.]
[N02AA02, opium, The metabolism of Opium can be decreased when combined with Chloroquine.]
[G04CA02, tamsulosin, The metabolism of Tamsulosin can be decreased when combined with Chloroquine.]
[C01AC01, ouabain, The serum concentration of Ouabain can be increased when it is combined with Chloroquine.]
[J01CF04, oxacillin, Chloroquine may decrease the excretion rate of Oxacillin which could result in a higher serum level.]
[P02BA02, oxamniquine, The metabolism of Chloroquine can be decreased when combined with Oxamniquine.]
[N05BA04, oxazepam, Chloroquine may decrease the excretion rate of Oxazepam which could result in a higher serum level.]
[J01MB05, oxolinic acid, The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Chloroquine.]
[C07AA02, oxprenolol, The metabolism of Oxprenolol can be decreased when combined with Chloroquine.]
[N02AA05, oxycodone, The metabolism of Oxycodone can be decreased when combined with Chloroquine.]
[N02AA11, oxymorphone, The metabolism of Oxymorphone can be decreased when combined with Chloroquine.]
[S01BC02, oxyphenbutazone, Oxyphenbutazone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[S01AA04, oxytetracycline, The risk or severity of neuromuscular blockade can be increased when Oxytetracycline is combined with Chloroquine.]
[H01BB02, oxytocin, The risk or severity of QTc prolongation can be increased when Oxytocin is combined with Chloroquine.]
[J04AA01, aminosalicylic acid, The risk or severity of methemoglobinemia can be increased when Aminosalicylic acid is combined with Chloroquine.]
[N05AH05, asenapine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Asenapine.]
[M03AC01, pancuronium, The therapeutic efficacy of Pancuronium can be increased when used in combination with Chloroquine.]
[J04AB30, capreomycin, Chloroquine may decrease the excretion rate of Capreomycin which could result in a higher serum level.]
[G04BE02, papaverine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Papaverine.]
[N05CC05, paraldehyde, The therapeutic efficacy of Paraldehyde can be decreased when used in combination with Chloroquine.]
[H02AB05, paramethasone, The metabolism of Chloroquine can be increased when combined with Paramethasone.]
[A07AA06, paromomycin, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Paromomycin.]
[J01MA03, pefloxacin, The risk or severity of QTc prolongation can be increased when Pefloxacin is combined with Chloroquine.]
[G04BD11, fesoterodine, The metabolism of Fesoterodine can be decreased when combined with Chloroquine.]
[C07AA23, penbutolol, The metabolism of Penbutolol can be decreased when combined with Chloroquine.]
[N05AG03, penfluridol, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Penfluridol.]
[M01CC01, penicillamine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Penicillamine.]
[J01CE09, penicillin G procaine, Chloroquine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.]
[N05CA01, pentobarbital, The metabolism of Chloroquine can be increased when combined with Pentobarbital.]
[L01XX08, pentostatin, Chloroquine may decrease the excretion rate of Pentostatin which could result in a higher serum level.]
[C04AD03, pentoxifylline, Chloroquine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.]
[N05AB10, perazine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Perazine.]
[C08EX02, perhexiline, The metabolism of Perhexiline can be decreased when combined with Chloroquine.]
[N05AB03, perphenazine, The metabolism of Perphenazine can be decreased when combined with Chloroquine.]
[N02BE03, phenacetin, The metabolism of Phenacetin can be decreased when combined with Chloroquine.]
[G04BX06, phenazopyridine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Phenazopyridine.]
[N06AF03, phenelzine, Chloroquine may decrease the excretion rate of Phenelzine which could result in a higher serum level.]
[A10BA01, phenformin, The metabolism of Phenformin can be decreased when combined with Chloroquine.]
[R06AB05, pheniramine, The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Chloroquine.]
[N03AA02, phenobarbital, The metabolism of Chloroquine can be increased when combined with Phenobarbital.]
[B01AA04, phenprocoumon, The metabolism of Phenprocoumon can be decreased when combined with Chloroquine.]
[V03AB36, phentolamine, Chloroquine may decrease the excretion rate of Phentolamine which could result in a higher serum level.]
[M02AA01, phenylbutazone, Phenylbutazone may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N03AB02, phenytoin, The metabolism of Phenytoin can be decreased when combined with Chloroquine.]
[L04AB06, golimumab, The metabolism of Chloroquine can be increased when combined with Golimumab.]
[S01AE05, levofloxacin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Levofloxacin.]
[B02BA01, vitamin K1, Chloroquine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.]
[J05AB12, cidofovir, Cidofovir may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[C08CX01, mibefradil, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Mibefradil.]
[N05AG02, pimozide, The metabolism of Pimozide can be decreased when combined with Chloroquine.]
[C07AA03, pindolol, The metabolism of Pindolol can be decreased when combined with Chloroquine.]
[C10AA05, atorvastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Atorvastatin.]
[J01CA12, piperacillin, The risk or severity of neuromuscular blockade can be increased when Piperacillin is combined with Chloroquine.]
[J05AE01, saquinavir, The metabolism of Chloroquine can be decreased when combined with Saquinavir.]
[P02CB01, piperazine, The metabolism of Piperazine can be decreased when combined with Chloroquine.]
[N05AC04, pipothiazine, The metabolism of Pipotiazine can be decreased when combined with Chloroquine.]
[N06BX03, piracetam, Chloroquine may decrease the excretion rate of Piracetam which could result in a higher serum level.]
[C09CA02, eprosartan, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Eprosartan.]
[S01BC06, piroxicam, The metabolism of Chloroquine can be decreased when combined with Piroxicam.]
[J01DD16, cefditoren, Cefditoren may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[J01MA11, grepafloxacin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Grepafloxacin.]
[J05AG02, delavirdine, The metabolism of Chloroquine can be decreased when combined with Delavirdine.]
[C09CA04, irbesartan, The metabolism of Chloroquine can be decreased when combined with Irbesartan.]
[D05AX05, tazarotene, The metabolism of Tazarotene can be decreased when combined with Chloroquine.]
[A10BG02, rosiglitazone, The metabolism of Chloroquine can be decreased when combined with Rosiglitazone.]
[L02BG03, anastrozole, The metabolism of Anastrozole can be decreased when combined with Chloroquine.]
[L04AC08, canakinumab, The metabolism of Chloroquine can be increased when combined with Canakinumab.]
[C03AA05, polythiazide, Polythiazide may increase the excretion rate of Chloroquine which could result in a lower serum level and potentially a reduction in efficacy.]
[J05AE03, ritonavir, The serum concentration of Chloroquine can be increased when it is combined with Ritonavir.]
[A10BH03, saxagliptin, Chloroquine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.]
[B05XA01, potassium chloride, Chloroquine may decrease the excretion rate of Potassium chloride which could result in a higher serum level.]
[C10AA08, pitavastatin, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Pitavastatin.]
[C07AB01, practolol, The metabolism of Practolol can be decreased when combined with Chloroquine.]
[C01BA08, prajmaline, The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Chloroquine.]
[P02BA01, praziquantel, The metabolism of Praziquantel can be decreased when combined with Chloroquine.]
[H02AB07, prednisone, Chloroquine may decrease the excretion rate of Prednisone which could result in a higher serum level.]
[R06AX05, antazoline, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Antazoline.]
[C01DX02, prenylamine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Prenylamine.]
[N01BB04, prilocaine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Prilocaine.]
[P01BA03, primaquine, The metabolism of Chloroquine can be decreased when combined with Primaquine.]
[N03AA03, primidone, The metabolism of Chloroquine can be increased when combined with Primidone.]
[M04AB01, probenecid, The metabolism of Chloroquine can be increased when combined with Probenecid.]
[C10AX02, probucol, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Probucol.]
[C01BA02, procainamide, The metabolism of Procainamide can be decreased when combined with Chloroquine.]
[S01HA05, procaine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Procaine.]
[L01XB01, procarbazine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Procarbazine.]
[C10AB05, fenofibrate, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Fenofibrate.]
[N05AB04, prochlorperazine, The metabolism of Prochlorperazine can be decreased when combined with Chloroquine.]
[G03DA04, progesterone, The metabolism of Progesterone can be decreased when combined with Chloroquine.]
[N05AA03, promazine, The metabolism of Promazine can be decreased when combined with Chloroquine.]
[R06AD02, promethazine, The metabolism of Promethazine can be decreased when combined with Chloroquine.]
[C01BC03, propafenone, The metabolism of Propafenone can be decreased when combined with Chloroquine.]
[A03AB05, propantheline, Chloroquine may decrease the excretion rate of Propantheline which could result in a higher serum level.]
[N05AC01, periciazine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Periciazine.]
[L01XH02, romidepsin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Romidepsin.]
[N01AX10, propofol, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Propofol.]
[N02AC04, propoxyphene, The metabolism of Dextropropoxyphene can be decreased when combined with Chloroquine.]
[C07AA05, propranolol, The metabolism of Propranolol can be decreased when combined with Chloroquine.]
[H03BA02, propylthiouracil, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Propylthiouracil is combined with Chloroquine.]
[C01AB01, proscillaridin, The serum concentration of Proscillaridin can be increased when it is combined with Chloroquine.]
[N02CC04, rizatriptan, Chloroquine may decrease the excretion rate of Rizatriptan which could result in a higher serum level.]
[B01AC09, epoprostenol, Chloroquine may decrease the excretion rate of Epoprostenol which could result in a higher serum level.]
[R03DC03, montelukast, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Montelukast is combined with Chloroquine.]
[N06AA11, protriptyline, The risk or severity of QTc prolongation can be increased when Protriptyline is combined with Chloroquine.]
[N05AX12, aripiprazole, The metabolism of Aripiprazole can be decreased when combined with Chloroquine.]
[N07XX07, dalfampridine, The risk or severity of seizure can be increased when Chloroquine is combined with Dalfampridine.]
[P02CC01, pyrantel, The therapeutic efficacy of Pyrantel can be increased when used in combination with Chloroquine.]
[J04AK01, pyrazinamide, Pyrazinamide may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[R06AC01, pyrilamine, The metabolism of Chloroquine can be decreased when combined with Mepyramine.]
[P01BD01, pyrimethamine, The metabolism of Chloroquine can be decreased when combined with Pyrimethamine.]
[P01AX05, quinacrine, The metabolism of Quinacrine can be decreased when combined with Chloroquine.]
[C01BA01, quinidine, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Quinidine.]
[P01BC01, quinine, The metabolism of Chloroquine can be decreased when combined with Quinine.]
[A02BA02, ranitidine, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Ranitidine.]
[C02AA02, reserpine, The metabolism of Chloroquine can be increased when combined with Reserpine.]
[J05AP01, ribavirin, Chloroquine may decrease the excretion rate of Ribavirin which could result in a higher serum level.]
[J04AB02, rifampin, The metabolism of Chloroquine can be increased when combined with Rifampicin.]
[J01AA09, rolitetracycline, The risk or severity of neuromuscular blockade can be increased when Chloroquine is combined with Rolitetracycline.]
[J01FA06, roxithromycin, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Roxithromycin.]
[N02BA05, salicylamide, Salicylamide may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[A07EC01, sulfasalazine, The risk or severity of methemoglobinemia can be increased when Chloroquine is combined with Sulfasalazine.]
[S01BC08, salicylic acid, Salicylic acid may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N05CA06, secobarbital, The metabolism of Chloroquine can be increased when combined with Secobarbital.]
[N04BD01, selegiline, The metabolism of Selegiline can be decreased when combined with Chloroquine.]
[J01GB08, sisomicin, Chloroquine may decrease the excretion rate of Sisomicin which could result in a higher serum level.]
[A12CD01, sodium fluoride, Chloroquine may decrease the excretion rate of Sodium fluoride which could result in a higher serum level.]
[V04CC01, sorbitol, Chloroquine may decrease the excretion rate of Sorbitol which could result in a higher serum level.]
[C07AA07, sotalol, The metabolism of Sotalol can be decreased when combined with Chloroquine.]
[L01CD04, cabazitaxel, The metabolism of Cabazitaxel can be decreased when combined with Chloroquine.]
[C03DA01, spironolactone, The metabolism of Chloroquine can be decreased when combined with Spironolactone.]
[N02BA03, choline salicylate, Chloroquine may decrease the excretion rate of Choline salicylate which could result in a higher serum level.]
[V09AB03, ioflupane I-123, Chloroquine may decrease the excretion rate of Ioflupane I-123 which could result in a higher serum level.]
[V09AA01, technetium Tc 99m exametazime, Chloroquine may decrease the excretion rate of Technetium Tc-99m exametazime which could result in a higher serum level.]
[V09AX06, florbetaben f-18, Chloroquine may decrease the excretion rate of Florbetaben (18F) which could result in a higher serum level.]
[V04CH02, indigo carmine, Chloroquine may decrease the excretion rate of Indigotindisulfonic acid which could result in a higher serum level.]
[N05CC01, chloral hydrate, Chloroquine may decrease the excretion rate of Chloral hydrate which could result in a higher serum level.]
[N03AG01, valproic acid, The risk or severity of QTc prolongation can be increased when Chloroquine is combined with Valproic acid.]
[M05BA04, alendronic acid, The risk or severity of myopathy, rhabdomyolysis, and myoglobinuria can be increased when Chloroquine is combined with Alendronic acid.]
[D07AB02, hydrocortisone butyrate, The metabolism of Hydrocortisone butyrate can be decreased when combined with Chloroquine.]
[D10AX03, azelaic acid, Azelaic acid may decrease the excretion rate of Chloroquine which could result in a higher serum level.]
[N05AL01, sulpiride, QT prolonging agents - QT prolonging agents]
[N05AC02, thioridazine, QT prolonging agents - QT prolonging agents]
[L01EX04, vandetanib, QT prolonging agents - QT prolonging agents]
[N06DA02, donepezil, QT prolonging agents - QT prolonging agents]
[S01AE07, moxifloxacin, QT prolonging agents - QT prolonging agents]
[C08EA02, bepridil, QT prolonging agents - QT prolonging agents]
[L01XX27, arsenic trioxide, QT prolonging agents - QT prolonging agents]
[J01MA09, sparfloxacin, QT prolonging agents - QT prolonging agents]
[S01AA26, azithromycin, QT prolonging agents - QT prolonging agents]
[B01AC23, cilostazol, QT prolonging agents - QT prolonging agents]
[J01FA09, clarithromycin, QT prolonging agents - QT prolonging agents]
[S01AE06, gatifloxacin, QT prolonging agents - QT prolonging agents]
[C01BD07, dronedarone, QT prolonging agents - QT prolonging agents]
[L01DB04, aclarubicin, QT prolonging agents - QT prolonging agents]
[N05AA01, chlorpromazine, QT prolonging agents - QT prolonging agents]
[N05AF03, chlorprothixene, QT prolonging agents - QT prolonging agents]
[S03AA07, ciprofloxacin, QT prolonging agents - QT prolonging agents]
[N06AB04, citalopram, QT prolonging agents - QT prolonging agents]
[L01EB10, mobocertinib, QT prolonging agents - QT prolonging agents]
[A04AA01, ondansetron, QT prolonging agents - QT prolonging agents]
[S02DA02, cocaine, QT prolonging agents - QT prolonging agents]
[C01BA13, hydroquinidine, QT prolonging agents - QT prolonging agents]
[P01CB01, meglumine antimoniate, QT prolonging agents - QT prolonging agents]
[L01XA03, oxaliplatin, QT prolonging agents - QT prolonging agents]
[A03FA02, cisapride, QT prolonging agents - QT prolonging agents]
[C01BA03, disopyramide, QT prolonging agents - QT prolonging agents]
[A03FA03, domperidone, QT prolonging agents - QT prolonging agents]
[N01AB08, sevoflurane, QT prolonging agents - QT prolonging agents]
[N05AD08, droperidol, QT prolonging agents - QT prolonging agents]
[N05AL02, sultopride, QT prolonging agents - QT prolonging agents]
[G04BD05, terodiline, QT prolonging agents - QT prolonging agents]
[S01AA17, erythromycin, QT prolonging agents - QT prolonging agents]
[C01BD05, ibutilide, QT prolonging agents - QT prolonging agents]
[N05AE03, sertindole, QT prolonging agents - QT prolonging agents]
[R06AX11, astemizole, QT prolonging agents - QT prolonging agents]
[R06AX12, terfenadine, QT prolonging agents - QT prolonging agents]
[C01BC04, flecainide, QT prolonging agents - QT prolonging agents]
[J02AC01, fluconazole, QT prolonging agents - QT prolonging agents]
[C01BD04, dofetilide, QT prolonging agents - QT prolonging agents]
[P01BX01, halofantrine, QT prolonging agents - QT prolonging agents]
[N05AD01, haloperidol, QT prolonging agents - QT prolonging agents]
[P01BA02, hydroxychloroquine, QT prolonging agents - QT prolonging agents]
[H01BA04, terlipressin, QT prolonging agents - QT prolonging agents]
[L01XX35, anagrelide, QT prolonging agents - QT prolonging agents]
[N05AC03, mesoridazine, QT prolonging agents - QT prolonging agents]
[N07BC02, methadone, QT prolonging agents - QT prolonging agents]
[N05AA02, methotrimeprazine, QT prolonging agents - QT prolonging agents]
[C01BD01, amiodarone, QT prolonging agents - QT prolonging agents]
[S01AE05, levofloxacin, QT prolonging agents - QT prolonging agents]
[N05AG02, pimozide, QT prolonging agents - QT prolonging agents]
[J01MA11, grepafloxacin, QT prolonging agents - QT prolonging agents]
[C10AX02, probucol, QT prolonging agents - QT prolonging agents]
[C01BA02, procainamide, QT prolonging agents - QT prolonging agents]
[N01AX10, propofol, QT prolonging agents - QT prolonging agents]
[C01BA01, quinidine, QT prolonging agents - QT prolonging agents]
[J01FA06, roxithromycin, QT prolonging agents - QT prolonging agents]
[C07AA07, sotalol, QT prolonging agents - QT prolonging agents]
